Louisiana State University

LSU Digital Commons
LSU Doctoral Dissertations

Graduate School

2003

Characterization of native and bypass human coronary artery
plaque deposits from the same heart: investigation of the
chemical form of calcium in human coronary artery plaque
deposits
Serigne Thiam
Louisiana State University and Agricultural and Mechanical College

Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations
Part of the Chemistry Commons

Recommended Citation
Thiam, Serigne, "Characterization of native and bypass human coronary artery plaque deposits from the
same heart: investigation of the chemical form of calcium in human coronary artery plaque deposits"
(2003). LSU Doctoral Dissertations. 612.
https://digitalcommons.lsu.edu/gradschool_dissertations/612

This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It
has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU
Digital Commons. For more information, please contactgradetd@lsu.edu.

CHARACTERIZATION OF NATIVE AND BYPASS HUMAN CORONARY
ARTERY PLAQUE DEPOSITS FROM THE SAME HEART: INVESTIGATION
OF THE CHEMICAL FORM OF CALCIUM IN HUMAN CORONARY ARTERY
PLAQUE DEPOSITS

A Dissertation
Submitted to the Graduate Faculty of the
Louisiana State University and
Agriculture Mechanical College
In partial fulfillment of the
Requirement for the degree of
Doctor of Philosophy
In
The Department of Chemistry

By
Serigne Thiam
B.S. University Cheikh Anta Diop of Dakar (Senegal), 1985
M.S. Pennsylvania State University, University Park, PA, 1997
August, 2003

ACKNOWLEDGEMENTS
I am grateful to Dr. Isiah M. Warner and Dr. James W. Robinson for inspiring me to
reach my potential goal and teaching me how to be a scientist.
Special thanks to my mom, Thioro Biteye, brothers, sisters, and friends in Senegal for
their patience and their every day prayers and blessing.
My gratitude goes to all my friends, Racine Kane, Denise Thiam, Hyacinthe Yarabe,
Hamidou Sy, Alassane Gueye, Dominique Delma, Hamady Diop, Dominique Duval
Diop, Moussa Sow, Constantina Kapnissi, Kimberly Hamilton, Bertha C. Valle,
Janet Taurus, Simon Mwongela, and Mary Kamande.
I would like also to thank Dr. Rezik Agbaria, Dr. Abdul Numan, Dr. Xiaofeng, Dr.
Nikki Gill, Dr. Maribel Rodriguez, Samuel Washington, Christy Ott, Gail Altanza,
and Robert Carver for their constant assistance.
I am appreciative of the Warner Family and the Warner Research group for their
unconditional support.
I also appreciate the assistance of Dr. Les Butler, Dr. Robert L Cook, Dr. Dale
Treleaven, Dr. Tracey McCarley, and Dr. Ron Reese, from the Department of
Chemistry of Louisiana State University.

ii

TABLE OF CONTENTS
Page
ACKNOWLEDGEMENTS…………………………………………………………ii
LIST OF TABLES……………………………………………………………...…...v
LIST OF FIGURES…………….…………………………………………………..vii
LIST OF ABBREVIATIONS……………………………………….……………..xii
TERMINOLOGY………………………………………………………………….xiv
ABSTRACT………………………………………………………………………..xvii
CHAPTER 1 INTRODUCTION…………………………………………………....1
Part I Background on Atherosclerosis………………………………..1
Part II Background on the Analytical Methods
Used in this Dissertation………………………………………..7
References……………………………………………………………..37
CHAPTER 2 ELEMENTAL ANALYSIS OF PLAQUE DEPOSITS
FROM HUMAN AORTA AND CORONARY ARTERIES…….....47
Introduction…………………………………………………………..47
Experimental Section………………………………………………...48
Results and Discussion……………………………………………….49
Conclusion…………………………………………………………….56
References………….. ………………………………………………...57
CHAPTER 3 CHARACTERIZATION OF NATIVE AND BYPASS
CORONARY PLAQUE DEPOSITS BY USE OF
SOLID STATE NMR………………………………………………..59
Part I. Investigation of the Chemical Differences
Between Native and Bypass Coronary Artery
Plaques from the Same Heart Using Cross
Polarization Magic Angle Spinning Nuclear
Magnetic Resonance (CP/MAS NMR)…………………..…59
Part II.Investigation of the Effects of Calcium
and Homocysteine on Cholesterol by Use of Solid State
13
C CP/MAS NMR………………………………………….69
References…………………………………………………………..78
CHAPTER 4 CHARACTERIZATION OF NATIVE AND
BYPASS HUMAN CORONARY ARTERY
PLAQUE DEPOSITS BY USE OF X-RAY METHODS………...80
Part I. High Resolution Three-Dimensional
iii

Visualization and Characterization of
Coronary Atherosclerosis in Vitro by Synchrotron
Radiation X-ray Microtomography and
Highly Localized X-ray Diffraction………………………..80
Part II. Characterization of Calcium
Deposits in Human Atherosclerotic
Plaques Using X-ray, Light Microscopy,
and Staining Methods………………………………………89
References and Notes………………...……………………………102
CHAPTER 5 CHARACTERIZATION OF PLAQUE DEPOSITS
USING CHROMATOGRAPHIC METHODS…………………..107
Part I Capillary Electrochromatography
of Cholesterol and Its Esters……………………………...107
Part II. Determination of Cholesterol and Its Esters
In Plaque From Bypass and Native Arteries
From the Same Human Hearts Using
Liquid Chromatography/ Atmospheric
Pressure Chemical Ionization Mass
Spectrometry………………………………………………123
References…………………………………………...……………135
CHAPTER 6 CONCLUSIONS AND FUTURE STUDIES…………………….139
Future Studies…………………………………………………….142
References…………………………………………………………143
VITA…………………………………………………………………….................144

iv

LIST OF TABLES
Page
1.5.1

Limits of detection for some biologically
relevant elements by the use of
the most abundant isotope in ICP-MS……………………………..11

1.5.2

Examples of spectral overlap interferences
encountered with ICP-MS…………………………………………..12

1.6.1

Spin number of nuclei ………………………………………………14

1.7.1

Nuclei spin Hamiltonian parameters………………………………..18

2.1

Concentration of minerals crystalline
plaque from heart patients in µmoles/g……………………………..50

2.2

Concentration of essential metals in
soft plaque (fatty streak) in µmoles/g……………………………….51

2.2-2.2a

Footnotes for 2.1 and 2.2…………………………………………....53

2.3

Concentration of minerals in native and bypass
coronary plaque deposits in µmoles/g………………………………55

2.3a

Footnotes for 2.3…………………………………………………….56

3.1

Chemical shift of 13C NMR of the main
functional groups…………………………………………………....61

3.2

Ratio of the area of the main functional
groups present in the plaque deposits in
comparison with model compounds ………………………………..65

3.3

Ratio of the peak area of the main functional
groups present in the reference in the standards…………………….66

3.4
4.1

Effects of calcium and homocysteine on
H NMR of cholesterol……………………………………………...77

1

Attenuation coefficients µ in cm-1
for each component at various x-ray energies
The densities of HAP, soft tissue and adipose
tissue are 3.14, 1.0 and 0.95 g/cm3, respectively...............................88

v

4.2

Fitted contributions of HAP and soft tissue to
the measured µ values in the calcified plaque………………………88

5.1

Source and description of the plaque deposits……………………..127

5.2

Weight percent of cholesterol and
cholesteryl esters from coronary plaque
deposit crude extracts……………………………………………...134

vi

LIST OF FIGURES
Page
1.1

A) Normal artery. B) Fatty streak plaque deposits.
C) Advanced atherosclerotic plaque deposits……………………….2

1.2

Illustration of two bypass arteries around the blockages………….....7

1.3

Inductively coupled plasma torch…………………………………....8

1.4

Inductively coupled plasma mass spectrometer…………………….10

1.5

A Schematic of an NMR spectrometer……………………………...17

1.6

Magic angle spinning is performed by rotating
at high speed a solid sample inclined at the magic
angle of 54.7 o to the static field……………………………………..20

1.7

Description of x-ray absorption process……………………………..22

1.8

x-ray absorption experimental set up.
Synchrotron radiation is used as an x-ray source……………….…...23

1.9

x-ray measurements to determine the distance
between planes and the plane of the x-ray waves.
The Bragg condition is fullfilled when 2a
is equal to nλ with nλ = 2 dsinθ...................................................…..25

1.10

A schematic of an TLC system……………………………………...27

1.11

A diagram of an HPLC system……………………………………...28

1.12

A schematic of an CE system……………………………………….30

1.13

Electrospray ionization mechanism…………………………………32

1.14

Atmospheric pressure chemical ionization………………………….33

1.15

Schematic representation of a TOF-MS…………………………….34

2.1

Calcium to phosphorus molar ratio
in calcified plaque samples………………………………………….54

2.2

Calcium to phosphorus molar ratio
in soft plaque samples……………………………………………….54

vii

3.1

13

3.2

13

3.3

31

3.4

31

3.4

The structures of homocysteine and its analogs……………………..71

3.6

13

3.7

Solid State

3.8

Solid State 13C NMR of cholesterol/homocysteine precipitates……..75

3.9

Solid Sate 13C NMR of cholesterol/Ca/homocysteine precipitates…..75

3.10

Chemical structure of cholesterol
and its and its proton active sites of the molecule…………………....76

4.1

Cross sectional image sequences along
the three different directions.
Sample A, B, and C were from
the coronary arteries of a 51, 55
and 70 year old white male, respectively.
The presence of calcium is indicated by the color.
Increasing concentration of calcium
changes color from orange to yellow…………………………………84

4.2

Powder x-ray diffraction patterns of calcium
deposits. In situ XRD patterns were acquired
at also the same beamline (17) by narrowing
the synchrotron radiation x-ray beam.
The incident monochromatic x-ray energy
was 25 KeV, equivalent to 0.496 Å wavelength
that is 3 times shorter than that of the frequently
used Cu Kα radiation. Debye-Scherrer pattern of one calcium
deposit in the SC native artery and (B) in
the SB bypass artery………………………………………………….85

C CP MAS-NMR of native and bypass
coronary plaque deposits from the same heart……………………....63
C CP MAS-NMR of native and bypass
coronary plaque deposits from the same heart………………………64
P CP MAS NMR of native and bypass
coronary plaque deposits from the same heart……………………....67
P CP MAS NMR of native and bypass
coronary plaque deposits from the same heart………………………68

C CP/ MAS NMR of homocysteine and
Ca-homocysteine complexes………………………………………...73
13

C NMR of cholesterol/Ca precipitates ………………..74

viii

4.3

Visualization of calcification in coronary arteries……………………86

4.4

Experimentally measured linear attenuation
coefficient of the calcified plaques. (A) In each
native artery. The monochromatic energies are
13.5, 12.5 and 11 KeV for the SA, SB and SC
arteries, respectively. (B) In each bypass artery.
The x-ray energies are 12.5, 12.5 and 15 KeV
for the SA, SB and SC, respectively. The calcified
tissues in the native arteries were selected from
the planar cross-sections of 340, 460 and 320,
respectively, and 56, 62 and 480 slices from the
bypass arteries (shown in Fig. 1A).
Chemical structures of cholesterol and twelve
ester derivatives in CEC separation………………………………....87

4.5

Ca-K edge XANES edge spectra of calcium salts…………………...95

4.6

Ca-K edge XANES spectra of plaque and model compounds……....96

4.7

Ca K edge EXAFS of plaques and hydroxyapatite………………….97

4.8

X-ray microprobe analysis of coronary plaque deposits…………….98

4.9

X-ray diffraction of hydroxyapatite and the plaque deposits……..…99

4.10

Microscope slides of native and bypass coronary arteries………….101

4.11

Microscope slides with silver stain of calciumsalts………..……….101

5.1

Cholesterol and its ester structures used in the CEC methods…..….113

5.2

Electropherograms of a mixture of cholesterol
and twelve ester derivatives at pH 8.0.
Using 25 % (v/v) THF/ 70 % (v/v) ACN /25 mM Tris.
The pH of the mobile phase was adjusted before
the addition of the organic modifiers with (a) HCl
and (b) TFA. Conditions: 20 cm x 100 µm i.d. fused
silica capillary packed with 3 µm ODS particles;
200 nm UV detection; 25 kV voltage, electrokinetic
injection (10 kV for 3 sec). ………………………………………....114

5.3

Effect of mobile phase composition on
the CEC separation of cholesterol derivatives.

ix

Conditions same as Figure 2 except
TFA was used for pH adjustment, and mobile phase
(THF/ACN) composition was varied……………………………….116
5.4

Effect of Tris concentration on the CEC separation
of a mixture of cholesterol and twelve ester derivatives.
Conditions same as Figure 5.2 except TFA was used
for pH adjustment, Tris buffer concentration was varied,
with 35 % (v/v)THF/ 60 % (v/v) ACN……………………………..118

5.5

Effect of applied voltage on the CEC separation
of a mixture of cholesterol and twelve ester
derivatives using 30, 25 and 15 kV. Conditions
same as Figure 5.2 except applied voltage was varied
from 15 kV to 30 kV. Mobile phase composition was
25 mM Tris, 35 % (v/v) THF/60 % (v/v) ACN/ 5% (v/v)
H2O, (pH adjusted with TFA to 8.0)………………………………..119

5.6

Effect of temperature on the separation of
a mixture of cholesterol and twelve ester
derivatives. Conditions same as in Figure 5.6
except 30 kV was used and the temperature was
varied from 20 oC to 60 oC………………………………………….120

5.7

Effect of polymeric sodium N-undecanoyl-L-glycinate
on the CEC separation of a mixture of
cholesterol and twelve ester derivatives.
Conditions same as Figure 5.6
except separation was performed at 30 kV and 25 oC.
a) Tris buffer (25 mM, pH 8) /THF/ ACN (5:35:60 v/v)
b) Tris buffer (25 mM, pH 8) /THF/ ACN (5:35:60 v/v);
with 5 mM polymeric sodium N-undecanoyl-L-glycinate………….121

5.8

CEC separation of crude extracts from
atherosclerotic plaque of a human aorta.
Conditions are: Tris buffer (25 mM, pH 8)
/THF/ ACN (5:35:60 v/v); with 5 mM
polymeric sodium N-undecanoyl-L-glycinate
using a 25 cm x 100 µm i.d. fused silica capillary
packed with 3 µm ODS particles; 200 nm UV
detection; 30 kV voltage, electrokinetic injection(15 kV for 6 sec)..122

5.9

Structures of cholesterol and its esters used
in APCI-MS analysis………………………………………………125

x

5.10

Standard chromatogram of cholesterol and
its esters using ultraviolet absorbance (λmax 200 nm).
Mobile phase was a mixture of 30%/ 70%
isopropanol/ acetonitrile and Bischoff Prontosil
C18 column, 120 Å, 3 µm, 100 x 4.6 mm at flow rate 1mL/m……….128

5.11

Calibration curves of cholesterol and its
esters using conditions as described in Figure 5.2…………………..129

5.12

A)Chromatogram using ultraviolet absorbance
of crude extracted from native coronary plaque.
Mobile phase was a mixture of 30%/ 70%
isopropanol/ acetonitrile and Bischoff Prontosil
C18 column, 120 Å, 3 µm, 100 x 4.6 mm
at flow rate 1mL/min. Numerous compounds
beside cholesterol and cholesteryl esters were detected..
B) Chromatogram of crude extracted from
native coronary plaque deposits using
m/z 369 as the detected fragment.
Only cholesterol and cholesteryl esters
were detected using peak 369 …………………………………..…..131

5.13

A)Chromatogram from ultraviolet absorbance
of crude extracted bypass coronary plaque
deposits. Mobile phase was a mixture of
30%/ 70% isopropanol/ acetonitrile and Bischoff
Prontosil C18 column, 120 Å, 3 µm, 100 x 4.6 mm
at flow rate 1mL/min. Numerous compounds
beside cholesterol and cholesteryl esters were detected..
B)Chromatogram of crude extracted from
bypass coronary plaque deposits using m/z 369
as the detected fragment. Only cholesterol and
cholesteryl esters were detected using peak 369……………………132

5.14

Proposed ionization mechanism for cholesterol
cholesteryl esters……………………………………………………133

6.1

Future studies……………………………………………………….142

xi

LIST OF ABBREVIATIONS
ABBREVIATIONS

NAME

CE

capillary electrophoresis

CEC

capillary electrochromatography

HPLC

high performance liquid chromatography

TLC

thin layer chromatography

MEC

micellar electrokinetic chromatography

SDS

sodium dodecyl sulfate

Poly-SUG

polymerized sodium N-undecenoyl sulfate

CMC

critical micelle concentration

ACN

acetonitrile

Tris

tris[hydroxymethyl]aminoethane

EOF

electroosmotic flow

APCI

atmospheric pressure chemical ionization

MS

mass spectrometry

ESI-MS

electro spray ionization-mass spectrometry

TOF

time-of-flight mass spectrometry

GC/MS

gas chromatography/ mass spectrometry

ICP-MS

inductively coupled plasma mass spectrometry

NMR

nuclear magnetic resonance

13

C

carbon-13

31

P

phosphorus-31

1

H

proton

xii

CH

methane

CH2

methylene

CH3

methyl

CP

cross polarization

MAS

magic angle spinning

ppm

parts per million

XANES

x-ray absorption near edge spectroscopy

EXAFS

x-ray absorption fine structure

XPS

x- ray photoelectron spectroscopy

SR-XMT

synchrotron radiation x-ray micro-tomography

xiii

TERMINOLOGY
Aorta
The main blood vessel that carries oxygenated blood away from the heart to the body
Vein
Blood vessels that transport oxygen-poor but, pulmonary blood away from the body
towards the heart
Artery
Blood vessels that carry oxygen but, pulmonary blood away from the heart to the body
Angina
Severe constricting pain that patients with heart disease often experience (e.g. when overexerting themselves)
Angiogram
Radiographic image of blood vessels in a living patient
Angioplasty
Procedure to open blocked blood vessel
Atherosclerosis
-Multi stage process
Hardening of change overtime sized arteries (characteristically irregular distribution of
lipid deposits in arterial intima. Then deposits are covered within fibrous cap.
Calcification
Deposition of calcium. in the arterial wall
Stenosis
Blockage, obstruction, or narrowing of the arteries
Hemorrhage
Bleeding
Thrombosis
Formation of blood clots inside of a blood vessel
Lymphocytes
Lymphocytes are types of white blood cells or leukocytes formed in lymphatic tissue.
They are extraordinarily diverse in their functions. The most abundant lymphocytes are:
B lymphocytes (B cells) and T lymphocytes (T cells).

xiv

Macrophage
Large scavenger cell present in connective tissue and many organs and tissues
Endothelium
The endothelium is located at the interface between the blood and the vessel wall
Acyl-CoA cholesterol acytransferase (ACAT)
The enzyme that esterifies cholesterol for storage
Osteopontin (OPN)
OPN is an acidic protein, with several Asp or Glu residues, which exhibits a high amino
acid homology between species (mouse, rat, human and pig). The protein is associated
with mineralized ion and contains calcium or hydroxyapatite-binding site.
Osteonectin
A protein that plays role in mineralization of covalently binds bone
Osteocalcin
A bone matrix protein
Matrix Gla protein (MGP)
The protein controls the formation and the restoration of bone. The protein has strong
affinity for calcium binding and can be crystallized in the form of hydroxyapatite.
Raised lesion
Raised lesion is characterized by the presence of two components in the plaque: the
fibrous cap and the atheroma.
Fibrous cap
The fibrous cap is a layer of fibrous connective tissue, which is thicker and less cellular
than the normal intima. The fibrous contains macrophages and smooth muscle cells.
Atheroma
The atheroma consists of a mass of necrotic lipid. Usually, the term refers to the mass of
fatty materials, but sometimes is used to describe advanced plaque deposits with lesions.
Fatty streak
Flat or slightly elevated lesions that contain intracellular and extracellular lipids in
intima. Fatty streaks are localized in the early stages of atherosclerosis
Crystalline deposits or hard plaques
Mass of organic and inorganic materials in the crystalline phase of the plaque deposits
Soft plaque
Smooth and fatty deposits, sometimes called amorphous plaque
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Terms Used in Pathology to Define the Types of Human Atherosclerotic Plaque
Lesions
PLAQUES

Atherosclerotic
Lesions

Type I

Initial lesion

Type II

Progression-prone type II
lesion
Progression-resistant type II

Type III

Intermediate lesion
(preatheroma)

Type IV

Atheroma

Type V

Fibroatheroma (type V
lesion)
Calcific lesion (type VII
lesion)
Fibrotic lesion (type VIII
lesion)
Lesion with surface defect,
and/or hematomahemorrhage, and/or
thrombotic deposit

Type VI

Lesions Defined Based on
Appearance

Fatty dot or streak

Early lesions

Atheromatous
plaque, fibrolipid
plaque, fibrous
plaque, plaque
Calcified plaque
Fibrous plaque
Complicated lesion,
complicated plaque

(1998 American Heart Association)

xvi

Advanced lesions,
raised lesions

ABSTRACT
Gradual deposits of lipids, proteins, and calcium on the coronary arterial walls
cause atherosclerosis, leading to blockage of the blood flow and possible heart attack.
Despite many studies, the mechanism underlying these processes remains unclear. In this
research, differences between native and bypass plaque deposits from the same heart
were examined. In addition, the crystalline and the amorphous plaques within these
native and bypass vessels were characterized. The techniques used to characterize the
deposits included inductively coupled plasma mass spectrometry (ICPMS), solid-state
nuclear magnetic resonance (NMR), high performance liquid chromatography (HPLC),
etc.
The results from the ICPMS technique showed that the concentrations of Ca and
P varied widely in the bypass arteries. In contrast, the concentrations of Ca and P were
higher in the native deposits. The molar ratios of Ca/P indicated that these elements
probably exist as hydroxyapatite in the calcified tissues. However, the molar ratio of
Ca/P in the soft tissue suggests that the phosphorus does not only exist as hydroxyapatite
but that at least half of it may also be organic.
The

13

C and

31

P solid-states NMR spectra of the native and bypass coronary

plaques from the same heart indicated that the concentrations of carbonyl groups, typical
of cholesterol esters, were similar between the native and bypass arteries. Significant
signals of carbonyl groups in the crystalline and amorphous plaques were due to amino
acids and proteins deposited in the plaques. Studies of

31

P showed that the phosphorus

exists mostly as hydroxyapatite in the crystalline native plaque, but a large proportion
exists as organic phosphorus.

xvii

To study the interactions of calcium with homocysteine and cholesterol, 13C solidstate NMR of homocysteine, Ca-homocysteine, Ca-homocysteine-cholesterol, Cacholesterol were performed. Significant spectral changes were also noted when calcium
was added to homocysteine and cholesterol.
The chemical forms and the distribution of calcium were studied using x-ray
absorption and light microscopy with silver staining. Finally, chromatographic methods
(CEC and APCI-MS) showed that only 40 % or less of the plaque in native or bypass
arteries consisted of cholesterol and its esters and the remaining, 60% were composed of
proteins, fatty acids, and phospholipids.
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CHAPTER 1
INTRODUCTION
Part I. Background on Atherosclerosis
Atherosclerosis
The accumulations of organic and inorganic materials in human coronary arteries
result in the formation of plaque deposits. Over time plaques continue to deposit on the
arterial wall reducing the artery diameter. Thus, there is a decrease in the blood flow,
which may eventually cause a heart attack or stroke. This process of plaque formation is
called atherosclerosis [1-9]. However, the mechanism responsible for plaque formation
is not well understood. Figure 1.1A shows a cross section of a normal artery. The blood
flows through the lumen. Then, plaque deposition starts to occur due to the dysfunction
of the endothelium of the arterial walls. Then lipoproteins become trapped in the arterial
wall, and monocytes, and lymphocytes adhere to the artery surface. Eventually, the
structural formation of the plaque deposits involves the lymphocytes forming initial
lesions known as fatty streaks (Figure 1.1B). Fatty streaks are deposits of intracellular
(foam cells) and extracellular lipids found in the intima. Gradually in the connective
tissue, smooth muscle cells form, which include fiber proteins, collagen, and
proteoglycans. Over time the cell components diffuse leading to the transformation of
monocytes to macrophages. In the later stage of the disease, more lipids and cholesterol
(free and esterified cholesterol) continue to accumulate on the arterial wall (Figure
1.1C). In summary, the lesions in the early stages are known as fatty streaks and the later
stages are known as fibrous plaques [1-9].
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Figure 1.1

A)

Cross section cut of a normal artery. B) Early stage of
atherosclerotic plaque deposits. There is a proliferation of smooth
cells; and presence T cells platelets, and leucocytes. These events
are indicators of atherosclerosis. C) Schematic of advanced
deposits with accumulation necrotic core, necrotic caps, and
macrophages [2].

There is a growing consensus that molecules, other than cholesterol, may enhance
the plaque formation, destabilize the existing plaques, or trigger inflammation and
degeneration of the arterial walls [10-17]. These advanced plaques have been associated
with high levels of cholesterol, cholesteryl esters and calcium [6-10]. For example,
Hirsch et al. revealed that in human atherosclerotic lesions, unesterified cholesterol and
calcium phosphate, in the form of hydroxyapatite, are in close proximity to each other
within the same plaque deposit [18]. Currently, it is not obvious whether cholesterol
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induces calcium deposition or vice versa, because in advanced plaque deposits, calcium
complexes and cholesterol derivatives are present in large crystalline aggregates [18].
Risk Factors
Homocysteine, an amino acid, when present in the blood contributes to
endothelium damage, harms smooth muscle of the arterial walls, and enhances plaque
formation. In 1969, McCully proposed that the homocysteine concentrations in the blood
are proportional to the risk of heart disease [19]. To explain the cause of injuries in the
arterial walls, Wang, et al. elaborated on McCully’s homocysteine medical hypothesis
[20]. Wang’s hypothesis indicates that a high presence of homocysteine in the blood
enables the formation of calcium/homocysteine related products [20].

High

concentrations of homocysteine in the blood favor interactions with calcium ions of the
calcium-dependent cell junction [20].

The calcium/homocysteine interaction causes

structure dissociation, which can damage the vascular endothelium.

The levels of

homocysteine in the body are influenced by diet, smoking, genetics, drugs, menopause,
exercise, and blood pressure [21-23].
Exposure to tobacco smoke also has a detrimental effect on heart disease [24-26]
by enhancing lesion formation. It is believed that free radicals in cigarette smoke cause
oxidation of lipids [27].

Previous studies comparing the susceptibity of lipid

peroxidation in smokers and non-smokers have been inconsistent [27]. One explanation
is the dietary difference between smokers and non-smokers. The dietary and serum
levels of antioxidants are lower in smokers than nonsmokers. Hence, the susceptibility of
lipid peroxidation in smokers depends on the levels of serum antioxidants. Miller et al.
demonstrated that cigarette smokers have higher degrees of lipid peroxidation than
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nonsmokers [30,31].

In addition, the Pathobiological Determinant Research Group

concluded that the serum thiocyanate concentration, a marker for smoking, was found in
high concentrations in plaque deposits.
The body naturally produces cholesterol for cell function, and lipoproteins assist
in the transportation of cholesterol into the blood stream. Lipoproteins include very lowdensity lipoprotein (VLDL), intermediate density lipoprotein (IDL), low-density
lipoprotein, and high-density lipoprotein (HDL). These lipoproteins have very complex
structures where the protein portion can be very diverse in structure and the lipid portions
have the composition of cholesterol and cholesteryl esters. HDL and LDL are the most
important lipoproteins because of their roles in the biological system. HDL, the so-called
“good” cholesterol, primarily transfers cholesterol back to the liver where it is
transformed into bile acids. However, LDL transports cholesterol from the liver to the
rest of the body and helps to facilitate lipid uptake by the cells. When LDL is degraded
in the cells, the protein portion is hydrolyzed to cholesterol and fatty acids to supply the
cellular membranes.
cholesteryl palmitate.

The excess of cholesterol is then stored as cholesteryl oleate or
These esters are synthesized by the process of acyl-CoA

cholesterol acytransferase (ACAT), which is enhanced by the presence of free cholesterol
[1, 32].
Calcification of the Arterial Wall
Vascular calcification is associated with the deposition of calcium phosphate
complexes (especially hydroxyapatite) in coronary tissues. It is well established that
calcification is one of the main characteristics of advanced atherosclerosis. Calcium
deposits in the arterial walls can be enhanced when the patient is diabetic or has some
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renal dysfunction. Recent studies have revealed that calcification is considered to be the
final stage of atherosclerosis progression [6-8]. Despite studies that are involved in the
characterization of complex proteins associated with vascular calcification, such as
osteopontin, osteonectin, esteocalcin, and matrix Gla protein (MGP), the mechanism
controlling the calcification of tissues remains unclear. However, there is some evidence
that serum phosphate levels are linked to calcification of tissues. Clinical studies have
shown that phosphate serum levels at higher-than-normal concentrations (1.0 to 1.5
mmol/L) correlate with vascular calcification. In those cases, most of the vascular
calcification occurs as a result of a mineral imbalance. Giachelli, et al, tested this
hypothesis by monitoring the mechanism controlling vascular calcification [33,34]. Their
finding suggested that human aortic smooth cells (HSMC) calcification was controlled at
least in part through a sodium-dependent phosphate transport-sensitive process. This kind
of procedure characterized the response of HSMC after they had been exposed to high
phosphorus levels.
Over the years, calcium and vitamin D have been prescribed to enhance
deposition of calcium in bones. However, the intake of the osteoregulatory molecules
may also have an impact on the calcium deposition in vascular walls [35]. To assess the
potential of osteo-regulation on the development of vascular calcification, Watson, et al.
investigated the vitamin D levels in serum in association with vascular calcification [35].
They found that vitamin D was inversely correlated with the progression of vascular
calcification in both populations. Furthermore, no correlation was found between the
extent of calcification and levels of osteocalcium and parathyroid hormones.

5

Proposed Treatments of Blocked Arteries
Atherosclerotic blockages of the coronary arteries can cause angina or heart
attacks. Usually, when the medication or the changes of lifestyle (diet, exercise, and
smoking) do not improve the heart health, the physician may recommend angioplasty or a
coronary artery bypass surgery. Due to the risks of these medical interventions, doctors
reserve angioplasty or bypass operation for patients who do not derive the maximum
benefit from medication [36,37].
In coronary angioplasty, a catheter with a small balloon on the tip is inserted into
an artery either in the groin or the arm. Then, the catheter is pushed into the coronary
arteries and the balloon tip is enlarged in order to open the blockage. This procedure is
called percutaneous transluminal coronary angioplasty (PTCA).

PTCA is not very

efficient for removing serious blockages [36,37]. Bypass surgery is an alternative
procedure to treat blocked arteries. Coronary artery bypass grafting involves the removal
of a healthy saphenous vein from the leg of the patient for use as the bypass artery. One
end of that vein is connected to the aorta, near the origin of the blocked coronary artery.
[36-39]. Then, the other end is connected to the lower end of the same coronary artery.
A similar bypass procedure can be performed using the internal mammary arteries instead
of the saphenous veins. Figure 1.2 is an illustration of a bypassed artery around the
blockage.
Although surgery may improve the heart conditions of patients, it is not clear why
about 40% of people who had bypass operations show symptoms of a new blockage
either in the bypass grafts or in another coronary artery within 10 years of the operation.
Furthermore, complications such as angina or death can occur in people with coronary
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bypass grafts [37-39].

Because of all the risks that can occur during or after the

operation, it is crucial to gain more understanding of the formation mechanism of the
coronary artery blockages.

Figure 1. 2 Illustration of two bypassed arteries around the blockages [36].
Part II. Background on the Analytical Methods Used in this Dissertation
Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
Inductively coupled plasma mass spectrometry (ICP-MS) determines the
concentrations of trace metals [40-43]. ICP-MS provides minimum interferences and can
be applied in a wide range of studies.

In addition, ICP-MS can be coupled with

separation instruments, such as high performance liquid chromatography (HPLC),
capillary electrophoresis (CE), and capillary electrochromatography (CEC). While ICP-
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MS is not the only available technique for metal analysis, it is sensitive to a wide group
of metals.
Inductively Coupled Plasma (ICP) Source
Plasma is an electrically neutral gas, which is composed of free moving electrons
and ions [40-48]. A monatomic gas in a plasma state can be described by use of the
following equation [40-48]
q

X=

∑

n =1

q

X n+ +

∑ n( e

−

),

(1.1)

n =1

where Xn+ is the ionic form with n charges and e- the charge of an electron.

Figure 1.3 A) Inductively coupled plasma source. B) Inductively coupled plasma
torch.
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For ICP, plasma is generated when argon flows through a radio frequency field.
Then, the argon plasma passes through a quartz tube, which has a 1 to 25 kW radio
frequency power source. Figure 1.3 has a schematic of an ICP torch [48]. When the
sample atoms reach the top of the source, they are exposed at temperatures ranging from
4000 to 8000 K. These temperatures are enough to allow complete atomization and
ionization interference effects.

The ionization of the plasma gas is ionized when

electrons and the argon molecules collide [46-70], i.e.,

e − + Ar = Ar + + e − + e − ,

(1.2)

where Ar is the argon molecule, Ar+ is the argon ion, and e- is the charge of an electron.
Then, through a recombination of processes, argon ions recombine with electrons to form
an excited argon molecule, Ar* [46-70], i.e.,
e − + Ar + = Ar * + hυ

(1.3)

Finally, analytes are ionized as a result of electronic interaction between species in the
plasma. Then, analyte ions are measured using mass spectrometry.
Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
In ICP-MS, samples are injected into the center of the plasma as aerosols. The
ICP plasma source dissociates the sample into its elemental composition. Then, the ions
migrate into the mass spectrometer, where they are separated based on their mass-tocharge ratio, (m/z) [71-80]. Figure 1.4 is a representation of an ICP-MS design. In most
cases, a quadrupole or magnetic sector mass analyzer is used to determine the m/z ratios
of the ion abundance.
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Figure 1.4 Schematic of inductively coupled plasma mass spectrometer.

The use of ICP-MS offers several advantages.

It is rapid, and it allows

simultaneous multi-element measurement at low detection (ppb or less for some
elements). In addition, ICP-MS also has relatively small matrix effects with a wide
dynamic range (up to 5–6 orders of magnitude), a precision ranging from 0.5 to 5%.
ICP-MS can be applied to gases, liquids, and solids [71-80]. However, this technique has
a few problems related to spectral interferences. Also, the analysis of solid samples can
be a challenge [72-74]. Such effects are more pronounced for the elements like calcium
(Ca) and sulfur (S). Therefore, the low limit of detection for elements like Ca, iron (Fe),
and S are usually affected [80]. Table 1.5.1 is an illustration of typical limits of detection
for different elements obtained in an ICP-MS analysis. Table 1.5.2 lists some examples
of spectral overlap interferences encountered with ICP-MS [76].
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Table 1.5.1 Limits of detection* for some biologically relevant elements by the use of
the most abundant isotope in ICP-MS [80]
Analyte

ICP-MS (ppb)

Al

0.05

As

0.01

Ba

0.001

Cd

0.005

Ca

0.5

Cu

0.005

Cr

0.005

Fe

0.1

Pb

0.001

Mg

0.05

Hg

0.001

K

0.5

P

1.0

Na

0.05

S

50

Zn

0.005

* The limit of detection (LOD) is the lowest amount that can be detected with precision
using a given method.
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Table 1.5.2 Examples of spectral overlap interferences encountered with ICP-MS
[74]
Ion

Mass

Ar+
ArH+
Ar+2
Ar2+

36,38,40
37,39,41
76,78,80
18,19,20

ArO+
OH n+
O2Hn+

52,54,56
16,17,18,19
32,33,34

Water

Fe Cr
OF
S

N+
NO+
N2+

14,15
30,31,32,33
28,29,30

Nitric acid
Matrix, traces
in plasma gas

N
P S Si
Si

C+

12,13

Traces in plasma gas

C

ArCl+
ClO+
CuCl+

75,77
51,53
98,100,102

Hydrochloric
acid matrix

As Se
V Cr
Mo Ru Pd

Ba2+

65,66,67,671/2,68
681/2,69
116
119
48,50,52

Th2+
U2+
2Mg+

Source

Plasma gas

+

If M present at high
concentration

Interferes with
elements of interest
Ca S K
K Cl
Ge Se Kr
OF

Cu Zn Ga
Cd Sn
Sn
Ti Ca V Cr

Underlined mass numbers are the most abundant isotopes of the element.
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Nuclear Magnetic Resonance
Background
The discovery and applications of NMR are marked by a number of very
important events. In 1924, Pauli demonstrated that nuclei have an angular momentum
[81]. In the same period, Gerlach and Stern determined the nuclear magnetic moments
using atomic beam measurement [82]. In 1938, Retri and colleagues observed the
resonance effect of nuclei when electromagnetic radiation was applied [83]. In 1946,
after several years of exploration, Block at Stanford University and Purcell at Harvard
University reported the first 1H NMR in liquid--H2O and solid paraffin wax [84]. In
1953, this work was rewarded with a Nobel Prize in Physics. Although NMR theory is
relatively complex, the development of the technique seems to be more promising.
Since its discovery by Felix Bloch and Edward Purcell, NMR has progressed
considerably [85-95].

For a number of years, proton NMR has been performed to

determine the physical properties of liquid and solid samples [94]. At present, NMR
experiments have been extended to a wide variety of nuclei due to the availability of
more powerful FT methods. In an effort to increase the sensitivity of the technique to
study biomolecular species, NMR methods, such as high resolution NMR and magic
angle spinning NMR have been developed [95-97].
Spin Properties
NMR measurements involve the interactions of radiowaves and the spinning of
precessing nuclei in a molecule [97,98]. Although the energy of radiowaves is small, the
nuclear spin of atoms is still affected. Each atom is characterized by its spin number or
angular momentum (Table 1.6.1). Even number of protons or neutrons result in a zero
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spin number. In comparison, an odd number of protons or neutrons result in a non-zero
spin number. For example,

12

C has an atomic weight of 12 equivalent to the same

number of protons and neutrons. Thus, the net spin is zero, and so is the angular
momentum. The zero angular momentum of 12C is not amenable to NMR experiments.
In contrast, the

13

C has an even number of protons and an odd number of neutrons;

therefore, its spin number is ½ (where in this case n=1). Such a spin value allows
NMR to be performed. Other ½ spin types of NMR include 1H-NMR,
19

31

13

C

P-NMR, and

F-NMR.

Table 1.6.1 Spin number of nuclei [97,98]
Number of mass = atomic weight

Atomic Number

Spin Number

(Proton + Neutron)

(Proton)

Odd

Odd or Even

1/2 , 3/2 , 5/2

Even

Even

0

Even

Odd

1, 2, 3

Nuclei with a non-zero spin quantum number, I, behave like a small magnet with
magnetic moment, µ , defined by the equation [90,91]

γ h[ I ( I + 1)]
µ =
2π

1/ 2

,

(1.4)

where h is the Planck’s constant and is γ the magnetogyric ratio. The projection of µ
along the z-axis, µz, is given by

µ z = mlγ h / 2π ,
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(1.5)

where ml is the magnetic quantum number with the allowed values ranging from (I1)……0, (-I+1)….-I. Overall 2I+1 represents the possible states of the nucleus. In the
absence of an applied magnetic field, ml is independent of the energy of the nucleus.
However, the degeneracy is cancelled when an external field is applied, and the energies
of the nuclei are given by [92]

E = − µ zB 0 = − mlγ B 0 / 2π ,

(1.6)

where B0 is the applied magnetic field in the z-axis direction.
At spin ½ the nuclei are associated with two states corresponding to ml = 1/2 and
–1/2. The difference of energy between the two states is [90,91]

f 0 = γ B 0 / 2π

,

(1.7)

where f0 is the Larmor frequency which arises from the interaction of the spinning
nucleus with the magnetic field causes the magnetic moment to precess at f0.
Mode of NMR
During the first 25 years of its discovery, NMR experiments were usually
performed using the continuous wave CW method.
spectrometers operate in the pulse-FT mode.

Currently; all modern NMR

The CW method consists of either

sweeping the magnetic field while holding the radio frequency constant or vice-versa. On
the other hand in FT-NMR, a short RF pulse is applied as a result of the magnetization,
and Mxy becomes nonzero [90-99]. Mxy processes around the z-axis at f0 [90-99]. The
nuclear magnetic moment precesses around Bo with no phase coherence. Due to the
population difference in energy states, there is a net-magnetization in the direction of Bo
along the z-axis. A nuclear induction signal from macroscopic magnetization in the
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transverse (x,y) plain Mxy is detected using the pulse/FT spectrometer. The value of Mxy
is zero at equilibrium.
In FT-NMR, a transient signal is induced by the precessing Mxy in a receiver coil
called the free induction decay (FID), which is orthogonal to the directions of Bo. Since
the RF probe excites the nuclei over a wide frequency range, the FID illustrates the time
domain signals from all the nuclei, which resonant in the given frequency range. Then,
the Fourier transform of FID gives the frequency domain spectrum.

In addition,

multiple-pulse NMR was introduced in order to be able to manipulate the nuclear
magnetization by RF pulses. Such methods allow the measurement of spin-lattice (T1)
and spin-spin (T2) relaxation times for each resonance [100]. In addition, multiple pulse
sequences can be used to increase the range of NMR applications.

A diagram of an

NMR spectrometer with its components is provided in Figure 1.5. The main component
of an FT-NMR spectrometer is a magnet in which the sample is inserted. The receiver
coil or transmitter surrounds the sample. The coil supplies the electromagnetic energy,
which is necessary for the spin to change its orientation. The nuclei are excited using a
pulse, which is provided by a controlled oscillator. This excitation of the nuclei is the
result of energy absorption.

Therefore, an amplified radiofrequency signal is induced.

The signal is transmitted through a coil. Then, the signal, called free induction decay
(FID), is amplified and transmitted to the detector. The detector computes the frequency
difference between the two states of the nuclei. Then, the Fourier transform program is
applied to the output in order to give a frequency domain spectrum.
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Figure 1. 5 A schematic of an NMR spectrometer.
Solid State NMR
Solid state NMR is a non-destructive technique, which is used to determine the
structures of molecules in the solid state. Many theoretical aspects of liquid NMR remain
applicable in solid state NMR. Solid and semisolid state NMR delivers lower resolution
spectra than liquid state NMR. In solid state NMR, poor resolution and broadband are
due to dipole-dipole interactions and chemical shift anisotropy [104]. For example the
solid dipole-dipole interactions are static, and they are a major source of line broadening
because the chemical shift anisotropic value is not averaged [104].
The lack of resolution can be explained using quantum chemical theories [105].
By considering the terms in the nuclear spin Hamiltonian, the cause of line broadening
can be understood in the following equation [106].
H = Hcs + Hj + Hd + Hq ,
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(1.8)

where Hcs,is the chemical shift, Hj ,is the scalar spin coupling term, Hd,is the dipolar
coupling, and Hq,is the quadrupolar Hamiltonian. The values of each term in the nuclear
spin Hamiltonian expression are reported in Table 1.7.1.
Table 1.7.1 Nuclei spin Hamiltonian parameters [106]

Sample

Hcs

Hj

Hd

Hq

Liquid

103-104

10-102

0

0

Solid

103-104

10-102

2-104

105-106

Equation (1.8) contains 4 terms, and each of them depends on the magnitude of the
dipole-dipole interactions in Hertz (Hz) for liquid and solids. For small molecules in
liquid, the dipolar (Hd) and the quadrupolar (Hq) terms vanish due to the rapid isotropic
molecular motion. [106]. The dipolar Hamiltonian for proton spin can be expressed as
[106]

Hd = γ 2 h 2 ∑ −
i, j

1
(r − 3ri ,z rj ,z )( I i I j − 3I i ,z I i ,z ) ,
r i, j i, j
2

(1.9)

where ri , j is the length of the internuclear vector, I is the spin operator, γ is the
gyromagnetic ratio, and h is the Planck’s constant
ri , j = r cosθ ,

(1.10)

where θ is the angle between the inernuclear vector and B0.
ri , j from equation 1.10 can be substituted into the equation 1.9..
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Hd = γ 2 h 2 ∑ −
i, j

1
(3 cos2θ i , j − 1)( I i I j − 3I i ,z I i ,z )
r i, j
3

(1.11)

In liquids, θ i , j is the function of rapid, tumbled, and isotopic effects. The angular factor in
equation 1.11 should be determined as [106]

〈 3 cos2 θ i , j − 1〉 =

∫

2π

0

(3 cos2 θ i , j − 1) sin θ dθ ;

(1.12)

thus, 〈 Hd 〉 = 0 . The quadrupole Hamiltonian has the same value as the dipolar
Hamiltonian; therefore, the spectra of solutions will depend only on the chemical shift
and scalar spin coupling Hamiltonian (Hcs + HJ). In contrast, in the solid state, the system
is rigid. As a result θ i , j is fixed with respect to Ho and Hd for two protons. The Hd and Hq
are larger than Hcs and Hj in the solid state because the motion is strongly anisotropic.
Therefore, the averaged Hd is incomplete. For both solids and semisolids the line is still
broad.
Line broadening occurs in solid sample due to restricted motions. Thus, the
dipolar couplings, D, are not fully averaged to zero, and have a time-averaged
dependence shown in the equation [107,109]

Dα r −3 (3 cos2 θ − 1) ,

(1.13)

where r is the internuclear distance and θ is the angle between the static field and the
internuclear vector. For solution samples where isotropically tumbling molecules occur,
D is averaged to zero [106]. In other words, the molecules move freely, and dipolar
couplings are not observed.

In contrast, when there are restricted motions, dipolar

couplings are present, which enhance the broadening of the NMR resonance [106]. Line
broadening is also due to sample heterogeneity like a liquid containing solid sample.
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Magic Angle Spinning (MAS)
Magic angle spinning has been applied in order to correct the line shape and to
improve the resolution of the solid state NMR spectrum. The line broadening from both
dipolar couplings and susceptibility continuities can be corrected by quickly rotating the
sample about the so-called magic angle θ = 54.7

o

[107,109], so that the dipole-dipole

term vanishes and the overall molecular motion becomes similar to the motion of the
molecules in solution. This magic angle spinning (MAS) has been used in solid samples
in order to average the chemical shift anisotropy [107,109]. In solution, dipolar splitting
and chemical shift anisotropy are reduced to zero due to the rapid isotropic motion and
the tumbling effects. As a result, the average orientation of the crystalline axes will be
equivalent to the magic angle, which leads to sharp lines. Therefore, sharp lines at the
isotropic chemical shift are obtained. Thus, this technique provides an enhancement of
the signal-to-noise ratio and greater information content. The experimental setup of the
sample probe with respect to the magnetic field is shown in Figure 1.6 where the sample
is oriented with respect to the applied field at the magic angle.

Figure 1.6 Magic angle spinning was performed by rotating at high speed. Solid
sample inclined at the magic angle of 54.7o to the static field.
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X-ray Spectroscopy
X-rays are electromagnetic radiation, which are located between visible light and
gamma rays in the electromagnetic spectrum [110-112]. X-rays are characterized by
their relatively short wavelength ranging from 0.01 Å to 100 Å [110-112]. X-rays can be
produced by converting the kinetic energy of charged particles into radiation resulting in
a continuous spectrum. In comparison, monochromic x-rays can be obtained when
exciting atoms collide with fast moving electron. These characteristic, monochromic
lines are obtained when electrons from the higher shells descend to fill a hole in a lower
shell. The energies of the characteristic lines depend on the energies of the two atomic
shells involved (higher and lower shell). Electrons in the atoms are distributed in a
succession of shells K, L, M, N, etc., which are labeled according to the decreasing
energy, respectively. For each element, each shell has specific edge energy [113-115].
For example, K-edge energy corresponds to the energy, which is necessary to "knock” an
electron out of the K shell.
The study in this dissertation was focused on XANES of calcium at the K edge.
The objective was to monitor the absorption coefficient when an electron was ejected
from the inner most shell of the atoms. This process produced information on the
chemical environment of the calcium complex.

In addition, x-ray absorption

spectroscopy was used to investigate the chemical forms of calcium deposits, and to
compare the calcium XANES spectra with the spectra of model compounds, such as
hydroxyapatite and fatty acid calcium salts.

21

X-ray Absorption Spectroscopy
During the x-ray absorption experiment, x-rays are absorbed by an atom causing a
core electron level from, K, L, or M shell to be ejected out of the atom into the continuum
(Figure 1.7). The atom is in the excited state, and has an empty electronic core hole.
Then, a higher-level core electron fills the core hole causing a fluorescence or Auger
electron emission. Such processes occur in discrete quantities energy, which can be used
to characterize the absorbing atom.

Figure 1.7 Description of x-ray absorption process
X-ray Absorption Near Edge Spectroscopy (XANES)
Biological specimens containing calcium have been studied using x-ray
absorption near edge spectroscopy. The technique has been widely applied in the
characterization of calcium in human skull bone, tissues, teeth, and milk. Peters et al.
(2000) studied the structure of bone samples by the use of x-ray absorption spectroscopy,
x-ray diffraction, and thermal analysis [117]. Kirtley et al. applied x-ray absorption
spectroscopy to determine the nitrogen-chemical structures in DNA and related
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molecules. [118,119]. The same authors assessed also the difference in the spectrum of
the C=C bond in DNA from the bond in bovine serum albumin. Sugiura et al. reported
Phosphorus K-edge x-ray absorption spectra of calcium phosphate compounds [120, 121]
Figure 1.8 is a diagram of an x-ray absorption experiment. XANES requires a
source of photon energy in the range of few keV. In the best cases, synchrotron radiation
is used as a light source. XANES spectra were collected by the use of an x-ray beam
emitted by the accelerated, relativistic particles in the storage ring traveling through a
beam tube and slits into a monochromator. Two parallel crystals were used to send a
single wavelength that is carried to an ion chamber that allows monitoring of the
absorption of the samples. A second ion chamber located behind the sample measured
the transmitted intensity.

Detectors can be simple devices, like the gas ionization

chamber in which detection of the ions is accomplished through the ionization of Ar, N2,
and CH4. In addition, solid-state detectors such as, Ge solid state, scintillation counter,
and photon diode can be used in fluorescence experiments [122].

Figure 1.8 X-ray absorption experimental set up. Synchrotron radiation is used as
an x-ray source.
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The energy dependence of the x-ray absorption coefficient, µ(E), at or above the
absorption edge of a selected element, µ, was measured. The absorption coefficient, µ,
depends on the x-ray beam intensity passing through the sample and the thickness of the
specimen, as shown in the equation [116, 117]
µ = (ρZ4)/AE3,

(1.14)

where ρ is the density of the element of interest in the sample, Z is the atomic number, A
is the atomic mass, and E is the energy of the x-ray. µ(E) can be determined using the
transmission or fluorescence mode.
In transmission mode, the absorption is measured based on the amount of light
transmitted through the sample using the equations [116,117]

dI = − µ Idx

(1. 15)

I
) = − µx
I0

(1.16)

ln(

where I 0 and I are the incident and the transmitted x-ray intensities and x is the
thickness of the sample.
In fluorescence mode, the filling of the deep core hole is detected through the
determination of the x–ray absorption coefficient that is given by

µ (E) ~

I
I0

(1.17)

X-ray Diffraction (XRD)
X-ray diffraction (XRD) provides structural information from crystal or powder
samples, in which the atomic constituents are periodically ordered [123,124]. X-ray
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diffraction has been widely applied in the characterization of biomaterials [125-128].
Diffraction patterns are obtained for each sample due to the interference of the radiation
with the crystal lattice or powdered samples. The diffraction pattern for any crystal
depends on the distribution of the electron around the central atom, the thermal vibration
of the central atom, the order of the atom in the unit cell, and the wavelength of incident
monochromatic beam [123, 124].
Under ideal circumstances, all the diffraction patterns are obtained under the
Bragg condition. The Bragg condition is met when the entire distance traveled by the xrays in the crystal, 2a, is equal to nλ, as shown in the equation

nλ = 2d sinθ

,

(1.18)

where θ is the angle of incidence of the x-ray beam with the crystal, d is the distance
between the crystal plans, n is the diffraction order, and λ is the wavelength of the x-ray
beam. Figure 1.9 is an illustration of an x-ray diffractometer. When coherent x-rays are
scattered by an ordered lattice, the crystal structure can be determined. The x-ray tube
has been commonly used as a source of monochromatic x-ray radiation of 8.4 keV.

Figure 1.9 Schematic of an x-ray diffractometer.
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Chromatography
Chromatography is an analytical method that allows the separation of mixture of
analytes as a result of their partitioning between the mobile phase and the stationary
phase [129]. Tswett, a Russian botanist, first introduced the technique in 1906 [126].
His objective was to separate and isolate green and yellow chloroplast pigments. The
separation was performed using a stationary phase of sucrose and a glass tube as a
support column [130]. Since then, chromatography has continued to develop. The
specific chromatographic techniques of thin layer chromatography (TLC), high
performance liquid chromatography (HPLC), and capillary electrochromatography (CEC)
are discussed.
Thin Layer Chromatography (TLC)
TLC is a planar chromatographic method, which is used to identify or confirm the
presence of biological markers in complex mixtures [133-136]. The stationary phase
consists of a plate (glass, metal, or plastic) coated with a thin layer of a solid adsorbent
(silica or alumina). Initially, a spot of the sample is placed at the bottom of this plate.
Then, the plate is dipped into a pool of the mobile phase in a closed glass cylinder
(Figure 1.10). The separation takes place when the mobile phase rises slowly with the
sample via capillary force. As the solvent diffuses, the sample mixture interacts with the
mobile phase and the stationary phase. The mobility of the components depends on the
solubility in the mobile phase and the analyte adsorption properties. When the mobile
phase reaches the top of the plate, the plate is removed from the glass chamber and dried.
The separation of the components is visualized using ultra violet light or staining
methods. The identification of analytes is based on the retardation factor (Rf) values.
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The Rf value of the compound is the ratio of the distance traveled by the mobile phase to
the distance run by the analytes on the plate.

Figure 1.10 A schematic of a TLC system: A.) The separation at to . B.) The
separation over time.
High Performance Liquid Chromatography (HPLC)
In HPLC separation, the sample is injected into a packed column with an
appropriate stationary phase [137-141]. Figure 1.11 is a representation of the different
components of a HPLC system. The separation mechanism is based on the partition of
the analytes between the stationary phase and the mobile phase. The elution of the
analytes is driven by pressure. The optimization of the separation is dependent on the
stationary phase and the mobile phase composition [137-139]. HPLC experiments can be
performed in either the isocratic mode or the gradient mode. In the isocratic mode, the
solvent composition is maintained constant during the time of the experiment, whereas, in
the gradient mode the solvent composition is varied throughout the run [137-139]. In
both cases, the analytes are identified by migration times and through a peak spiking
procedure.
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Figure 1.11 A diagram of an HPLC system.

The HPLC separation of most biological compounds has been performed using
the reversed phase mode. In such cases, the stationary phase is composed of a non-polar
matrix (C8, C18), and the mobile phase is a polar solvent. The mobile phase is usually a
mixture of water and a polar organic modifier like methanol or acetonitrile [137-139]. In
reversed phase-HPLC, separation is the result of hydrophobic interactions between the
non-polar stationary phase and the hydrophobic group of the analytes. Hydrophilic
analytes interact less with the stationary phase. Thus, they will elute faster. In contrast,
hydrophobic analytes will elute at much longer time. Other types of stationary phases
have been developed for specific compounds. For example, ion-pairing reagents have
been bonded to the stationary phase in the separation of proteins [140-141].
Multiple detection techniques have been associated with HPLC.
common is the ultra-violet (UV) detector.
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The most

However, other detectors such as light

scattering, conductivity, Fourier transform infra-red (FTIR), laser induced fluorescent
(LIF), mass spectrometry (MS), and nuclear magnetic resonance (NMR) have been used
[142-146]. Among these combined techniques, HPLC-MS has become the most useful.
Capillary Electrophoresis
Capillary electrophoresis (CE) is an electrophoretic method where the analyte
separation is based on the analyte in the presence of an applied electric field.

A

schematic of a CE instrument is shown in Figure 1.12. Both ends of the capillary are
submerged in buffer vials where one end is the positive electrode, and the other end is the
negative electrode.

Then, a high voltage (max. 30 kV) is applied across the two

electrodes. A small amount of sample at nanoliter level is injected at one end of the
capillary and the sample migrates through the capillary. The injected species will diffuse
depending on the electroosmotic flow, which is caused by the deprotonation of the free
silanol group on the wall of the silica capillary. The positively charged counter-ions from
the solution and the negatively charged ions at the capillary wall create a zeta potential, ζ,
which causes the diffusion of the ions towards the cathode. The process enables the
separation of the molecules regardless of their charge. The separation is optimized by
controlling the analyte migration velocity. The migration velocity, µ, of the analyte
depends on the electrophoretic mobility, µe, and electrosmotic mobility, µeo, yields [149152]

µ = µ e + µ eo .

(1.19)

Then, the migration time, t, of the analyte is given by

t=

l
lL
=
µE µV

,

(1.20)
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where l is the length of the capillary to the detector, L is the total capillary length, V is the
applied voltage, and E is the electric field.

Figure 1.12 A schematic of an CE system.

The analytes in the capillary are detected using an UV or an LIF detector. The
advantages of CE reside in its high separation power, its low sample size, and its short
analyses time [153-156]. CE is a powerful analytical technique, which permits high
selectivity separation of complex mixtures. In addition, CE can provide high sensitivity
when coupled with mass spectrometry.
Other forms of CE have also been developed for the separation of more specific
types of analytes (neutral analytes, proteins, lipids).

Among those are capillary

electrochromatography (CEC), micellar electrokinetic chromatography (MEKC),
capillary gel elctrophoresis, and capillary isotacophoresis [157-159]. In this research,
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CEC was used to characterize the cholesterol (esters) composition of the plaque. CEC
provided high separation efficiency of charged and neutral analytes. In addition, high
selectivity separation was obtained by the use of high concentrations of organic modifiers
(methanol, acetonitrile, and tetrahydrofuran) [160]. In CEC, a column packed with silica
particles (LC stationary phase) is used to perform the separation, as a result of the pluglike flow driven by the application of a voltage.
Mass Spectrometry
Mass spectrometry (MS) is used on structural elucidation of biomolecules [161].
When it is coupled with liquid chromatography (LC), the technique can provide
molecular weight identification of biological compounds.

Techniques, such as

electrospray ionization mass spectrometry (ESI-MS), atmospheric pressure chemical
ionization (APCI), and matrix assisted laser desorption ionization mass spectrometry
(MALDI-MS) have been used with success for structural information of organic and
inorganic compounds [161-164].
Electrospray Ionization Mass spectrometry (ESI-MS)
In electrospray, the ionization process is obtained by use of an electric field.
Charged droplets are formed at the exit of a capillary tube with a weak flux. The electric
field induces the accumulation of charged droplets located at the end of the capillary.
Then, the charged droplets are exposed to nitrogen, leading to the droplets shrinking due
to evaporation. Finally, a quasi-molecular ion is released as a result of strong charge
repulsions [161]. The ions that are formed from these processes are first selected by the
mass analyzer, and then detected using an electron or photomultiplier detector. Figure
1.13 shows a scheme of an ESI-MS ionization mechanism.
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Figure 1.13 Electrospray ionization mechanism.
Atmospheric Pressure Chemical Ionization (APCI-MS)
APCI-MS provides the ionization of labile and nonvolatile substances, so they can
be measured in the mass spectrometer. The ionization of the analyte molecules results
from collision with discharge from a corona needle containing ion gas.

During the

collisions, there is a loss of internal energy, which is accompanied by the interchange of a
proton. Therefore, the process is known as gas phase ionization process. A consequence
of the proton transfer is the ionization of the analytes. This occurs when the proton
affinity of the analytes is greater than that of the solvent. Figure 1.14 is an illustration of
the APCI-MS.
APCI-MS offers some advantages over conventional methods, such as electron
impact ionization mass spectrometry [163]. The strength of the technique is that there is
no need to introduce the liquid flow directly into the vacuum chamber.
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Figure 1.14 Atmospheric pressure chemical ionization.
Time-Of-Flight Mass Spectrometer (TOF-MS)
In TOF-MS, ions of different mass are accelerated using a uniform kinetic energy.
The ions with different velocities will reach the detector at different times for a given
distance. The most common type of TOF-MS is the one that uses a pulsed ion source
where a voltage pulse extracts the ions from the source. Figure 1.15 is a design of a
TOF-MS. A potential gradient between A and B of the field free flight tube allows the
ions to travel with a uniform kinetic energy, and to be separated based on their m/z ratio
at the repeller C. Finally the sorted ions are detected at D with photo-multiplier tube.
The main concern for this set-up is the resolution. However, the resolution can be
optimized by increasing the ion flight time [164-166].
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Figure 1.15 A schematic representation of a TOF-MS.
Scope of Dissertation
Atherosclerotic plaque development is a dynamic process in which plaque
formation is in equilibrium with liquid blood and solid deposits. Although many studies
have been performed, the process of this equilibrium with respect to the chemical
composition of the deposits remains unclear. In addition, the factors that affect the
equilibrium are not well understood. In order to better understand this equilibrium
process, differences between bypass and coronary artery plaque deposits from the same
heart were investigated.

Bypass plaque deposits are chemical materials, which

accumulate after bypass surgery.

In contrast, native coronary artery deposits are

associated with the materials that accumulate during the lifetime of the patient.
Therefore, the chemical differences between the two plaques may imply changes in body
metabolism in later life. Such changes may be related to factors, such as diet, lifestyle,
and age. Previous studies conducted by Robinson and Murungi (1992) indicated that
calcium and phosphorus concentration in bypass were an order of magnitude higher than
in the native artery [10]. The complexities of the deposits depend on the acuity of the

34

disease. However, the effects of these components, and other factors that affect such
equilibrium are not well understood. Studies in this dissertation were performed by the
use of inductively coupled plasma mass spectrometry (ICP-MS), x-ray absorption near
edge spectroscopy (XANES), nuclear magnetic resonance (NMR) spectroscopy, x-ray
diffraction (XRD), and chromatography.
Elemental Analysis By Use Of Inductively Coupled Plasma Mass
Spectrometry
The objective of these studies was to compare the distribution of the minerals in
native and bypass plaque deposits and to investigate the chemical forms of calcium in
both native and bypass plaque deposits. The ion metals (Ca, P, Mg, Zn, Cu, Cr, and Cr,
F, and S, etc.) present in the plaque were characterized. To determine the chemical form
of calcium in comparison with hydroxyapatite (Ca10(PO4)6 (OH)2,), the molar ratios of Ca
to P were calculated for each sample. Then, this ratio was compared to the theoretical
molar ratio of Ca to P in hydroxyapatite. The differences between calcified samples and
the atheroma deposits were established by comparing the molar ratios of Ca to P.
Solid-State NMR
Magic angle spinning solid state NMR was performed on the plaque deposits from
native and bypass coronary arteries, and on cholesterol, homocysteine, and homocystine
model compounds. The method allowed the determination 1) of the chemical differences
between the native and the bypass coronary plaque deposits and 2) the study of the
interactions of calcium with homocysteine and cholesterol. In the 13C NMR spectrum of
calcium-homocysteine, the chemical shifts of the carboxylate, alkene or carbon attached to
the sulfur were examined. In addition, the contribution of the proteins in the plaque was
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determined using the ratio of the carboxylic to the aliphatic peak areas in

13

C NMR

spectra.
X-ray Spectroscopic Methods
X-ray absorption, x-ray diffraction, and imaging (light microscopy, scanning
electron microscopy and microtomography) techniques were used to examine the native
and bypass coronary plaque deposits. These techniques were used to determine the
distribution of the calcium within the plaque. In the early stage of the plaque formation
calcium is distributed heterogeneously in the arterial walls. X-ray absorption methods
were used to localize the calcium deposits and to investigate their chemical forms.
Ca K-edge XANE spectroscopy, light microscopy, and x-ray diffraction were
performed on coronary plaque deposits, fatty acid calcium salts, and hydroxyapatite. In
addition, silver staining methods were used to localize, and to identify the forms of
calcium in the deposits. A comparison of the x-ray data of the deposits with model
compounds allowed determination of the chemical forms of calcium in the calcified and
atheroma plaques.
Capillary Electrochromatographic (CEC) and High Performance Liquid
Chromatrography –Atmospheric Pressure Chemical Ionization Mass
Spectrometric (HPLC-APCI) Analysis
The lipids from the native and bypass coronary artery deposits from the same
heart were extracted using the Folch method liquid extraction procedure. The chemical
compositions were determined using HPLC, CEC, and TLC. In addition, APCI-MS was
used to confirm the presence of cholesterol and its esters in chromatograms of the crude
extracts.
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CHAPTER 2
ELEMENTAL ANALYSIS OF PLAQUE DEPOSITS FROM HUMAN AORTA
AND CORONARY ARTERIES
Introduction
Previous studies in our laboratory showed that calcium and phosphorus
concentration in bypass arteries were significantly higher than in native arteries [1].
However, these samples were obtained from living heart bypasses that had complete
obstructions. These deposits were obtained by drilling the clogged arteries. Due to the high
risk of death, this medical operation is no longer practiced.
Minerals play a vital role in the proper function of the cardiovascular systems.
Potassium, Na, Ca, and Mg play an important role in conduction and contraction of muscles
including those of the heart. Studies using rats have shown that Cu deficiency results in
degradation of the smooth muscle of the arteries and formation of coronary aneurysms [1,2].
A high Zn to Cu ratio results in hypercholesterolemia in a lot of animals [3,4]. Lead and Al
have been implicated in some forms of heart diseases, especially hypertension. Aluminum
has been known to interfere with the metabolism of Ca and Mg [3-5]. Aluminum has been
shown to play an important role in many other biological processes [6,7]. Aluminum may
bind to phospholipids, which can cause the alteration of the lipid membrane of the arterial
wall. Lead is known to have high affinity for sulfurhydryl groups, and can interfere with
membrane function. Homocysteine has been associated with heart disease although its
function is not known. The presence of homocysteine should result in an elevated sulfur
concentration. Therefore, the sulfur concentrations as well as the concentrations of the other
metals mentioned above were determined. The sulfur concentration can be used as an
estimation of the presence of homocysteine and its analogs in the plaque deposits.
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According to many studies, the elemental composition of the plaque deposits and the
nature of the coronary plaque deposits are related to the age of the patients [8,9]. However,
there is little information on the concentration of minerals in these different types of plaque.
The objective of this study was to determine the concentration of numerous elements in
various type plaques, and to note differences and similarities found in the results. Such
results may be used to establish a correlation with disease, ages, gender, and lifestyle, which
can be used as predictor of further events.
Experimental Section
Sample Collection
Dr. Richard E. Tracy of Louisiana State University Health Sciences Center in New
Orleans, LA, provided the coronary arteries and the aorta samples. The plaque deposits were
collected from the coronary arteries of unanimous cadavers for whom the cause of death was
usually unknown. The plaque was removed carefully to avoid contamination from the
intima. The deposits from each coronary artery were classified as soft or crystalline plaques.
The classification was based on the visual examination. After their collection, the plaque
deposits were placed in clean plastic vials, and stored in the freezer at –70 °C until analyzed.
Sample Digestion
An amount of plaque was weighed (~ 50 mg). It was placed in an acid cleaned
beaker and 30 to 50 ml of concentrated nitric acid were added. The solution was heated at
low temperature (~40 °C) on a hot plate for 48 hours. The volume was reduced to about 2
ml and the resulting solution was transferred quantitatively into a 10 ml volumetric flask and
diluted with distilled water. Each sample was analyzed in duplicate. A sample blank was
prepared by reducing the 50 ml of nitric acid to 2 ml through heating, and by performing the
dilution to 10 ml with distilled water.
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Instrument
The sample solutions were analyzed for metals using inductively coupled plasma
(ICP) model (Optima 3000) online with a quadrupole mass analyzer. The limit of detection
of the ICPMS methods of each element was given in Table 1.5.1 chapter I. The elemental
composition of each sample was determined after the analysis of the standard solutions.
Calibration curves were developed using standards with various concentrations of metals of
interest (Ca, P, S, Mg, K, Na, Cu, Pb, and Cr) run under the same conditions as the samples.
The calibration curves were used to calculate the concentration of metals in the plaque
samples.
Results and Discussion
Metal Concentrations
The elemental compositions for the calcified and the atheroma plaques are shown in
Tables 2.1 and 2.2. The description for each sample is shown in the corresponding legend.
Samples 11, 12, 13, and 14 were taken from one heart, and the samples 22, 23, 24, and 25
were taken from another heart. It can be seen from these samples that there is a variation in
metal concentration within the same heart or aorta sample.
In general, all the concentrations were at the

mole/g level, except for Ca and P,

which were at the mmole/g level in the calcified plaques. These two elements were about an
order of magnitude higher in concentrations in the calcified plaque than in the atheroma
plaque. The concentrations of sodium and magnesium were about an order of magnitude
higher in the atheroma plaque than in the calcified plaque, albeit at significantly lower levels
than the calcium and phosphorus concentrations. The copper and sulfur concentrations were
marginally higher in atheroma plaque than in calcified plaque. However, no significant
differences could be discerned for Zn, Fe, Al, Si, and Ba
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Table 2.1. Concentration of minerals in calcified plaques (µmoles/g)
Samples

Ca

P

Na

K

Mg Zn

Cu

Ba

Pb

Fe

Al

Si

S

1

2000

1000

10

20

30

1.0

0.03

0.01

0.2

2.0

0.1

1.0

50

2

5000

2000

20

20

80

1.0

0.02

0.07

0.4

1.0

0.3

2.0

50

3

2000

2000

20

30

60

4.0

0.02

0.03

0.3

1.5

0.1

2.0

50

4

4000

3000

30

20

10

2.0

0.03

0.04

0.5

1.0

0.9

2.0

50

5

3000

1000

60

10

50

44

0.03

0.02

*

0.0

0.1

1.0

50

0.2

80

*

6

200

200.0

80

30

20

2.0

1.00

0.02

0.1

0.0

7

1000

700.0

20

30

30

2.0

0.03

0.01

*

1.0

*

0.2

40

8

5000

2000

20

20

80

10

0.03

0.02

0.2

0.0

*

0.8

50

9

1000

1000

10

40

30

1.0

0.01

0.03

0.2

1.0

0.1

1.0

50

10

1000

1000

10

30

30

1.0

0.01

0.10

0.01

1.0

2.0

0.6

40

11

6500

4500

25

30

40

5.0

0.03

*

0.01

1.0

*

0.3

70

12

3000

2500

20

25

35

3.0

0.04

0.02

*

1.0

0.1

0.2

60

13

2500

1000

20

30

45

2.0

0.02

0.01

*

1.5

0.2

0.3

65

14

2700

1500

30

35

50

6.0

0.05

0.02

*

2.0

0.2

0.1

60

50

Table 2.2. Concentration of minerals in atheroma plaques (µmoles/g)
Samples

Ca

P

Na

K

Mg

Zn

Cu

Ba

Pb

Fe

Al

Si

S

15

400

80.0

200

50

5

1.0

0.1

0.20

0.10

10

12

0.2

100

16

60.0

70.0

200

30

6

40

0.1

*

0.01

2.0

0.4

0.3

80.0

17

10.0

40.0

90.0

30

2

1.0

0.1

0.02

0.01

20

1.2

10

50.0

18

10.0

400

100

40

4

1.0

0.3

*

0.01

1.0

*

*

10.0

19

10.0

30.0

90.0

40

3

1.0

0.8

*

0.01

1.0

*

*

10.0

20

1.00

30.0

90.0

40

4

1.0

0.3

0.01

0.01

1.0

*

2.0

50.0

21

3.00

30.0

40

30

2

1.0

0.8

*

0.01

1.0

0.3

0.3

30.0

22

7.5

8.0

100

25

5

2.0

0.1

*

0.1

0.3

*

0.3

50.0

23

6.0

6.5

85

30

4

2.5

0.1

*

*

0.2

*

0.2

45

24

7.0

6.5

90

30

6

3

0.2

*

*

0.4

*

0.2

65

25

9.0

8.0

95

40

3

2

0.4

*

*

0.1

*

0.3

60

51

Table 2.1-2.2a: Footnotes for 2.1 and 2.2
Sample ID
1
2
3
4
5
6
7
8
9
10
11
12
13
14

15
16
17
18
19
20
21
22
23
24
25

Description

Age and Gender

Plaque from aorta
Plaque from an aorta
Plaque from an aorta
Plaque from an aorta
Plaque from a native coronary
Plaque from a native coronary
Plaque from a native aorta old
Plaque from a bypass coronary artery
A mitral valve
A mitral valve
Plaque from aorta
Plaque from aorta
Plaque from aorta
Plaque from aorta

80 year old male
80 year old male
90 year old male
70 year old male
70 year old male
70 year old male
70 year old male
70 year male
70 year old white male
70 year old white male

Plaque from an aorta
Plaque from an aorta
Plaque from an aorta
Plaque from thoracic aorta
Plaque from aorta
Plaque from abdominal aorta
Lymphoma materials
Plaque from an aorta with lesions
Plaque from an aorta with lesions
Plaque from an aorta with lesions
Plaque from an aorta with lesions

60 year old female
70 year old female
90 year old male
40 year old female
40 year old female with stroke
40 year old woman with stroke
40 year old woman.
55 year old male
55 year old male
55 year old male
55 year old male

55 year old male
55 year old male
55 year old male
55 year old male

The mineral concentrations were higher in the calcified plaques than in the atheroma
plaques. The calcium and phosphorus concentrations were at least an order of magnitude
higher in calcified plaque than in atheroma plaque.

The sodium and magnesium

concentrations were about an order of magnitude higher in soft plaque than in crystalline
plaque. Copper and sulfur levels were marginally higher in soft plaque than in calcified
plaque. In some samples, the lead concentrations were quite high in the calcified plaque, but
not in the atheroma plaque. The concentrations of the other metals (Zn, Fe, Al, Si, Ba) were
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very low in concentration, and there were no discernable differences in their concentrations
between calcified and atheroma plaques.
In these studies most of the plaque samples collected from women were atheroma
plaque. However, the majority of samples from men hearts were crystalline. This may have
either been accidental or a characteristic of deposits in the different sexes. The differences in
composition between the physical form of atheroma and calcified plaques made the
comparison of metal concentrations between samples from men and women impossible.
Calcium to Phosphorus Ratio
The molar concentrations of Ca and P in calcified and atheroma plaque are presented
in Figures 2.1 and 2.2, respectively. The expected molar ratio of Ca and P in hydroxyapatite
is shown as a line in the figures. In the calcified plaque, the Ca to P molar ratios are similar
to that expected from hydroxyapatite (Figure 2.1).

In the atheroma plaque, the P

concentrations were significantly higher relative to Ca indicating the possible presence of
phospholipids, phosphoprotein, adenosine triphosphate, guanine triphosphate, and
phosphocreatine. (Figure 2.2). No conclusions could be drawn as to the chemical form of
the Ca in this case.
The overall studies indicate a better correlation of calcium to phosphorus ratio in the
hard plaque with hydroxyapatite than in the soft plaques. In some samples, the relative
concentrations of phosphorus to calcium were too high to be hydroxyapatite. Thus, the
phosphorus may be attached to organic molecules, and the calcium may complex with amino
acid residues of protein, cholesterol, or phospholipids.
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Figure 2.1 Calcium to phosphorus molar ratio in calcified plaque samples.

Figure 2.2 Calcium to phosphorus molar ratio in atheroma plaque samples
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Table 2.3 Concentration of minerals in native and bypass coronary plaque deposits
(µmole/g)
Samples

Ca

P

Na

K

Mg

Zn

Cu

Pb

Fe

Al

Si

S

1

180

220

109

3

22

0.6

0.04

0.03

0.2

1.1

0.6

23

2

55

71

160

9

29

0.2

0.6

0.004

0.01

1.0

0.4

50

3

200

85

80

26

16

0.4

0.02

0.007

1.0

2.0

0.2

36

4

750

763

171

61

16

1

0.01

0.001

3.0

4.0

0.6

82

5

5000

180

286

30

160

0.3

0.02

0.001

7

1

1

80

6

85

270

293

12

13

1

0.06

0.006

3

6

0.5

140

1720

280

120

27

25

0.6

0.06

0.006

1

5

0.9

36

720

102

56

15

2

1

0.06

0.003

0.5

3

0.6

24

9

700

109

400

6

5

0.5

0.03

0.02

0.4

4

2

34

10

2.2

380

44

8

16

0.3

0.02

0.4

3

0.7

1
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7
8

55

Table 2.3a: Footnotes for 2.3
Sample
1
2
3
4
5
6
7
8
9
10

Description
Native coronary artery
Bypass coronary artery
Native coronary artery
Bypass coronary artery
Native coronary artery
Bypass coronary artery
Native coronary artery
Bypass coronary artery
Native coronary artery
Bypass coronary artery

Age
55 year old male
55 year old male
70 year old male
70 year old male
47 year old male
47 year old male
56 year old male
56 year old male
55 year old male
55 year old male

The concentrations of the metals in the native and bypass coronary arteries were also
determined using ICPMS. The concentrations of the minerals present in the bypass and the
native plaque deposits are shown in Tables 2.3. The overall distribution of metals in the
native and the bypass coronary artery plaque deposits is very different. Calcium and P were
high in the native coronary plaque deposits, and much lower in the bypass coronary plaque
deposits. The Ca to P molar ratio was higher than 1.66. Therefore, the calcium deposits in
the native deposits are associated with hydroxyapatite. The low Ca to P molar ratio in the
bypass is due to the variably high concentration of the P in the bypass deposits. These
results might indicate that the deposits were not crystalline enough, and Ca was not in the
hydroxyapatite form. In addition, essential elements, such as Mg, Zn, and S were found in
the native and bypass deposits. The concentrations of Mg varied in the native and bypass
deposits.
Conclusion
The concentrations of minerals were found to be higher in the calcified plaque
samples than in the atheroama plaques. The differences in concentration of Cu and S were
also observed in the calcified and atheroama plaques. It is not obvious whether or not the
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high concentrations of Ca and P in the calcified plaques would affect the chemical form of
calcium which was statistically estimated to be comparable to hydroxyapatite. In contrast,
the above argument is rejected in the atheroma plaques where in average Ca and P
concentrations were lower in the atheroma plaques.
From the hydroxyapatite Ca to P molar ratios, the minerals in the crystalline plaque
primarily exist in the form of hydroxyapatite. However, the low mineral concentrations
indicate that the major component of the calcified plaque is organic in nature.

In

comparison, hydroxyapatite is present in the atheroma plaque, but much of the phosphorus is
organic in nature. The organic phosphorus may be an important. In contrast, calcium may
play an equally important role at this and later stages. Finally, the low sulfur levels indicated
that homocysteine was not a major component.
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CHAPTER 3
CHARACTERIZATION OF NATIVE AND BYPASS CORONARY PLAQUE
DEPOSITS BY USE OF SOLID STATE NMR
Part I. Investigation of the Chemical Differences Between Native and Bypass
Coronary Artery Plaques from the Same Heart Using Cross Polarization Magic
Angle Spinning Nuclear Magnetic Resonance (CP/MAS-NMR)
Introduction
The composittion of atherosclerotic plaque has been studied using a combination
of methods, such as scanning electron microscopy, x-ray spectroscopy, thermal analysis,
and chemical analysis [1-7].

Weinmann et al. described the use of infrared (IR)

spectroscopy to determine cholesterol and cholesterol esters present in the plaque
deposits [8,9].

The liquid-crystalline phases of carotid plaque deposits have been

determined by use of high-resolution
spectroscopy and

13

13

C nuclear magnetic resonance (NMR)

C CP/MAS-NMR [10-12]. Warschawski et al. performed similar

studies using a combination of MAS-NMR spectroscopy and two-dimensional
Heteronuclear Overhausser Effect Spectroscopy (HOESY) on lipid membranes [13,14].
In this dissertation, CP/MAS NMR was used to investigate chemical differences between
deposits from native and bypass coronary arteries from the same heart.
Experimental Section
Sample Preparation
Dr. Richard E. Tracy of the Department of Pathology of Louisiana State
University Health Sciences Center in New Orleans provided the native and bypass
coronary arteries. Both native and bypass coronary arteries were removed from the same
heart of cadavers. The collected native coronary arteries were completely clogged
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whereas, the deposits in the bypass varied. After removal, the samples were kept frozen.
For the NMR experiments, the arteries were opened longitudinally to expose the inside
layers for the removal of the deposits. After collection, the samples were ground using a
mortar pestle to facilitate the packing of the sample in the NMR rotor.
Experimental Conditions
The

13

C and 1H CP/MAS spectra were acquired on a Chemagnetics Infinity 400

MHz (9.4 T) NMR spectrometer. The

13

C chemical shift standard was the methyl

resonance of hexamethylbenzene (δ = 17.35 ppm). The proton radiofrequency (RF)
power, at the spectrometer frequency of 400.059499 MHz, was set to a 4.25 µs 90° pulse
for cross polarization.

The contact time was 100 µs.

The number of scans was

approximately 1000 and the delay between pulses was 3 seconds. Samples were spun in
a 5 mm zirconium rotor with dry N2 at a rate of a 5 kHz at room temperature. A spectral
width of 50 kHz (20 µs dwell).
Phosphorus-31 spectra with proton decoupling were acquired at room
temperature. The 31P chemical shift was set with external 85% H3PO4 at δ = 0 ppm. The
phosphorus RF power was set equivalent to a 10 µs 90° pulse. Approximately 1000
scans were acquired with a delay between pulses of 1.5 seconds. A spectral width of 250
kHz (4 µs dwell).
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Results and Discussion
Carbon-31 CP/MAS NMR
Using 13C solid state NMR, the native and bypass coronary plaque deposits were
examined. Representative NMR spectra are shown in Figures 3.1 and 3.2. The

13

C

NMR spectra were complex in the region (0-75 ppm) corresponding to the aliphatic
group of the steroid backbone of cholesterol and cholesteryl esters [15,16]. But, the
complexity was not due to this.

Rather it was doubtlessly due to the presence of

hydrocarbon groups of the phospholipid, protein, and triglyceride contents of the plaque
deposits.

Table 3.1 Chemical shift of 13C NMR of main functional groups [16]
Chemical Shift (ppm)

Functional Group

0-50

Aliphatic carbon

10-20

S-CH3

110-135

Aromatic

55-65

αC of the amino acid

105-130

Double bond

170-180

Carboxylate

The unsaturated carbons in cholesterol and cholesteryl esters have signals located
between 120 to 130 ppm. The deposits from the native coronary arteries are usually
firmer than those from the bypass arteries. Such physical changes between deposits may
change the peak shape at 25 ppm. This signal was assigned to the chemical shift of
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carbon of the methyl group in aliphatic side chain of cholesterol and cholesteryl esters,
and may be restricted to motions due to the crystalline of the sample. Therefore, in the
crystalline deposits, the signal of the methyl group, which is adjacent to the aliphatic
group of cholesterol backbone, remains broad. Similar differences at ~55 ppm and 175
ppm resonance chemical shift were observed. The signal at 55 ppm was less enhanced in
the deposit from the native artery than in the bypass, which could indicate a lower
concentration of double bonds in the deposits from the native arteries than from the
bypass arteries.
To examine the 13C NMR spectra of the plaques, the ratio of the carboxylate peak
(~175 ppm) was compared to the total peak areas (0-75 ppm). The results in the different
plaque samples are shown in Table 3.2. On average, the ratio was 1 to 5 suggesting that
one carboxylate correlated with 5 other carbons. This 1 to 5 ratio does not correspond to
a cholesteryl ester area ratio where the ratio is about 1 to 40 (Table 3.3).
Previous studies have shown that the cholesterol and cholesterol esters
composition constituted no more than 40% of these samples. The high carboxylic group
content must originate in the remaining 60% of the plaque indicating a ratio of 1 to 3 or 1
to 4. This strongly indicates the presence of large quantities of protein in the plaque.
Phosphorus-31 CP/MAS-NMR
The

31

P CP/MAS-NMR spectra of hydroxyapatite and phosphotidylcholine were

used to identify the resonance chemical shifts of the phosphorous components in the
plaques. The

31

P CP/MAS-NMR spectra of the native and bypass coronary plaques

obtained are shown in Figures 3.3 and 3.4. Two well resolved phosphorus peaks from
organic phosphorus (-0.6 ppm) and hydroxyapatite (2.6 ppm) were identified in the
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bypass plaque samples and all other soft plaque deposits. In contrast, only one

31

P

resonance peak was found in the crystalline plaque deposits, which corresponded to
hydroxyapatite. Since atherosclerosis is a progressive dynamic process, calcification may
also be a progressive dynamic process. However, it should be noted that the calcium and
phosphorus concentrations are at the ppm level and cannot account for the overall
crystallinity of the hard plaque. It follows that the bulk of this crystalline material is
organic in nature. Furthermore, the crystalline material would be more physically stable
than the soft amorphorus plaque.

Figure 3.1 13C CP/MAS-NMR of native and bypass coronary plaque deposits from
the same heart.
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Figure 3.2 13C CP/MAS-NMR of native and bypass coronary plaque deposits from
the same heart.
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Table 3.2. Ratio of the peak area of the main functional groups present in the plaque
deposits in comparison with model compounds
Samples

Heart 1

Heart 2

Heart 3

Heart 4

Heart 5

Area Ratio
Carboxylic/
Aliphatic 13C NMR

Area Ratio
Alkene/
Aliphatic 13C NMR

Native

0.20

0.10

Bypass

0.10

0.09

Native

0.05

0.02

Bypass

0.20

0.15

Native

0.19

0.13

Bypass

0.10

0.05

Native

0.18

0.07

Bypass

0.22

0.14

Native

0.19

0.08

Bypass

0.18

0.07
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Table 3.3. Ratio of the peak area of the main functional groups present in the
reference standards
Area Ratio
Carboxylic/
Aliphatic 13C NMR

Area Ratio
Alkene/
Aliphatic 13C NMR

Cholesteryl
linoleate

0.03

0.20

Cholesteryl oleate

0.03

0.10

Cholesteryl
palmitate

0.03

0.08

Fatty acid
(hexadecanoic
acid )

0.01

0.0

Tryglyceride
(Propane 1, 2, 3
triyl tripalmitate

0.06

0.0

Triglyceride
(propane 1, 2, 3,
triyl trimyrisate)

0.09

0.0

Standard Samples
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Figure 3.3 31P CP MAS NMR of native and bypass coronary plaque deposits.
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Figure 3.4

31

P CP MAS NMR of native and bypass coronary plaque deposits from
the same heart.

Conclusion
Magic angle spinning solid state NMR was successfully used to characterize the
native and bypass plaque deposits from the same heart.

Results indicate that the

composition of the deposits in the native and bypass arteries are different in some
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respects, but vary widely in composition. The large broad band on the 13C NMR at 175
ppm indicates the presence of significant quantities of protein in all deposits.
There appears to be more double bonds in the plaque in the bypass arteries than in
the native arteries. The phosphorus in the native arteries seems to be primarily in the
form of hydroxyapatite, while the phosphorus in the bypass and other soft tissue is likely
due to organic-phosphorus compounds.
Part II. Investigation of the Effects of Calcium and Homocysteine on Cholesterol by
Use of Solid State 13C CP/MAS-NMR
It has been shown that the presence of homocysteine in the blood is a flag for
potential heart problems [17-20]. The function of homocysteine is not known, and the
chemistry involved is not understood. Since homocysteine is an amino acid that has an
easily oxidized thiol group, it can damage the endothelium cell by generating reactive
free radical oxygen species. This process can promote clot formation, and homocysteine
thiolactone can precipitate LDL. An increase of the interactions of LDL with
endothelium cells leads to the formation of platelets aggregates [20]. Ca is present in
coronary plaques and it is not known if homocysteine is present in the coronary plaque.
However homocysteine is present in the blood at concentration ranging from 10 to 12
µmol/L. 80% of the homocysteine in the plasma is protein bound and the remaining 20%
are oxidized homocysteine, homocysteine-cysteine and free homocysteine [21]. The
questions that arise are the following (1) do homocysteine and Ca interact with or without
cholesterol, and (2) what is the implication in the plaque formation?
To answer the above questions, the reactions between homocysteine, cholesterol,
and Ca were studied chemically. These experiments were conducted using 13C NMR on
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homocysteine, cholesterol, and the mixtures of homocysteine with Ca, cholesterol with
Ca and homocysteine with cholesterol and Ca. The reactions were signified by changes
in chemical shift or changes in the peak shape.
Introduction
The structures of homocysteine and its related sulfur containing amino acids are
shown in Figure 3.5. These amino acids are highly reactive due to the thiol group, which
can be readily oxidized [22-25].

In the past, most research was focused on the

autoxidation properties of homocysteine. In comparison, few investigations examined
the reactivity of homocysteine with metal complexes.

Homocysteine damages the

endothelium cells. This, in turn, leads to injuries on the arterial walls. The ability of Ca to
form a stable complex with homocysteine has not been demonstrated yet. Recently,
homocysteine has been associated with the risk of coronary diseases [25,26]. Future
findings of the complexation of Ca with homocysteine and its analogs might help to
explain the injuries and the healing process that take place in the coronary arteries.
Over the years, some evidence of the coordination of calcium with amino acid
was reported [27,28].

These studies tried to gain a clear understanding of tissue

calcification. Many research groups synthesized and characterized calcium amino acid
complexes. Most results indicated that the complexes were either dimers or chain like
polymers [27,28]. Furthermore, the coordination of amino acids with Ca through the
carbonyl group shows that calcium is linked to oxygen [29,30]. For example Tang et al.,
performed potentiometric measurements, which explained that the oxygen in the carbonyl
group was involved in the coordination of calcium based upon the slight depression of the
Ca2+amino acid titration curve [22]. Similar work was also conducted by Maeda et al.,
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using NMR spectra of

14

N,

15

N, and the

17

O in the determination of the interactions of

calcium with glycine, DL-alanine, and β-alanine. They found that binding of calcium to
both amino acids was established by progressively adding Ca2+ to an amino acid solution.
While adding Ca2+ ions progressively, the evidence that Ca2+ was bound to both
carboxylate groups within the complexes was determined based on further broadening of
the NMR signals of the

14

N and

17

O nuclei [29-31]. Although no significant shift was

observed, the authors concluded that Ca binds very weakly to the ligand. Using Raman
and Infrared spectroscopies, similar observations were observed about calcium
complexing with the ligands.

Figure 3.5 Chemical structures of homocysteine and its analogs.
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Experimental Section
Chemicals
Calcium chloride, homocysteine, and cysteine were purchased from SigmaAldrich (St-Louis, MO). Distilled water was obtained from the system provided by US
Filter United State Filter Corporation.
Chemical Reaction
Calcium chloride (ca. 1.0 M), salt, and homocysteine (ca. 0.2 M) in aqueous
solution at pH=7.4 were allowed to react in inert conditions for 24 hours. The precipitate
was washed three times with distilled water and two times with pure ethanol. Then, the
milky product was dried under a stream of nitrogen for 30 minutes. The final product
was stored in a sealed vial in the refrigerator until further analysis.
Results and Discussion
13

C NMR Spectra of Calcium-Homocysteine

The

13

C NMR spectra of cholesterol, Ca-cholesterol, homocysteine, Ca-

homocysteine-cholesterol, and homocysteine-Ca complexes were reported.

The

13

C

NMR spectra of free homocysteine and calcium-homocysteine are shown in Figure 3.6.
Upon addition of calcium,

13

C NMR spectrum of Ca-homocysteine shows the chemical

shifts of the carboxylate at 176 ppm, and the secondary carbon at 56 ppm. The chemical
shift ranging from 0 to 70 ppm indicates a major shift, in comparison with pure
homocysteine. The downfield shift is indicative of calcium homocysteine interactions via
the sulfur and the carboxylic group. There was no major carboxylic shift in the 13C Cahomcysteine solid-state NMR spectrum. Perhaps Ca interacts weakly with homocysteine
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at the carboxylic group. Possible rearrangement of the structural complex can also favor
direct interactions of Ca with the sulfur group [22,23].

Figure 3. 6 13C CP/MAS-NMR of homocysteine and Ca-homocysteine complexes.

The interactions of Ca with cholesterol with and without homocysteine were also
studied. Both precipitates were analyzed using solid state 13C NMR. The spectra of the
reaction products were compared with free cholesterol.
cholesterol were previously described using solid state

13

The active sites of free

C NMR (Figures 3.7-3.9). In

these spectra the chemical shifts of the carbon attached to the hydroxyl, the alkene, and
the methyl groups were monitored. The Ca-cholesterol NMR spectra indicated a shift of
the alkene. Hence, a change of the peak shape (120-130 ppm) was noticed. The results
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illustrated that the alkene group interacts with Ca. The results imply that Ca may interact
with cholesterol in the plaque. Such interactions might initiate phase changes of the
plaque. In contrast, there were no major changes in the solid state
cholesterol-homocysteine compared to the solid state

13

13

C NMR of Ca-

C NMR of free homocysteine.

The active role of Ca might be inhibited by the presence of homocysteine.

Figure 3.7 Solid State 13C NMR spectra of Cholesterol/Ca precipitates.

These preliminary results are very promising. However, more studies needed to
be performed in order to monitor the kinetics of the reaction of Ca-homocysteinecholesterol. Due to the possible release of peroxide by homocysteine, the presence of
oxidized cholesterol in the reaction products is expected.
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Figure 3.8 Solid State 13C NMR of cholesterol/homocysteine precipitates.

Figure 3.9 Solid State 13C NMR of cholesterol/Ca/Homocysteine precipitates.
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Effect of calcium and homocysteine on cholesterol stability: a proton NMR case
study
Liquid 1H NMR was also performed on the reaction products. Slight chemical
shifts of the proton attached to the alpha and the beta carbon were observed on the Cahomocysteine solution NMR.

The following cholesterol Figure 3.10 illustrates the

proton active sites of the molecule. The changes of the chemical shift of these protons
were monitored when Ca was added to the homcysteine solution. The changes of the
chemical shifts were reported in Table 3.4.

Figure 3.10 Chemical structure of cholesterol. The bullets represent the proton
active sites of the molecule.
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Table 3.4 Effects of calcium and homocysteine on cholesterol conformation
Cholesterol
Active sites

1

A
B
R

H NMR
5.35
3.50
0.68

Cholesterol/Ca

Cholesterol/Hcy

1

1

H NMR
5.40/ 5.70
3.50
0.68

H NMR
5.40
3.60
0.67

Cholesterol/Ca
/Homocysteine
1
H NMR
5.35
3.40
0.69

The peaks in the 1H NMR spectrum of the cholesterol/Ca are broader than the
peaks

on

the

1

H

NMR

cholesterol/Ca/homocysteine.

spectra

of

the

cholesterol/homocysteine

and

This observation leads to the conclusion that the

interactions of Ca with cholesterol are much stronger than in the cases of
cholesterol/Ca/homocysteine.
Conclusion
The 13C and 1H NMR spectra of Ca-homocysteine, Ca-cholesterol-homocysteine,
and Ca-cholesterol reaction products were compared with the NMR spectra of cholesterol
and homocysteine. Observation of the spectrum of Ca-homocysteine suggests some
differences in comparison with the free homocysteine NMR spectrum. These changes
are mainly observed for chemical shifts ranging from 0 to 75 ppm. The presence of these
extra resonance peaks is likely due to the formation of disulfite group, and their
interactions with Ca. A major chemical shift change was not observed at the resonance
chemical shift of the carboxylic group when calcium was added to the free homocysteine
solution. However, the liquid 1H NMR of homocysteine and Ca-homocysteine revealed a
slight proton chemical shift, as a result of adding Ca. This data shows that Ca might
contribute to the formation of these aggregates, although strong interactions between Ca
and the free homocysteine may not exist. The evidence of the formation of the disulfite
77

group may favor the presence of multiple carboxylic groups that increase the chance for
Ca to bind.
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CHAPTER 4
CHARACTERIZATION OF NATIVE AND BYPASS HUMAN CORONARY
ARTERY PLAQUE DEPOSITS BY USE OF X-RAY METHODS
Part I. High Resolution Three-Dimensional Visualization and Characterization of
Coronary Atherosclerosis in Vitro by Synchrotron Radiation X-ray
Microtomography and Highly Localized X-ray Diffraction
Introduction
Recently, a number of imaging techniques have been used to image
atherosclerosis either in vivo or in vitro, including magnetic resonance imaging [1-4],
angiography [5-9], ultrasonography [10], computed tomography (CT) [11], electron beam
tomography (EBT) [12], magnetic resonance angiography [13], etc.

The spatial

resolution of most of these clinical imaging techniques is greater than 0.5 mm. Although
they can identify and characterize complex atherosclerotic lesions, their resolutions are
still not satisfactory for imaging the details of micron-sized plaque, such as coronary
calcifications. High resolution images of atherosclerosis is needed for research purpose,
particularly for calcification studies. Calcification is correlated very intimately with
atherosclerosis [14, 15].

A close correlation between the extent of coronary artery

calcification and the burden of coronary artery diseases (CAD) has been confirmed [10,
12]. Currently, EBT is the ״gold  ״standard for calcium detection in the coronary arteries.
Its in-plane resolution is approximately 0.5 mm, with a slice thickness of about 3 mm.
To our knowledge, most EBT images are in two-dimensional (2-D). Images of coronary
artery calcifications at higher resolution and in three-dimensional (3-D) have not been
reported yet.
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In this dissertation, high-resolution 3-D visualization of coronary atherosclerosis
by use of synchrotron radiation x-ray microtomography (SR-XMT) method is reported.
Like conventional CT, the SR-XMT technique measures volumetric information, and it
provides pictorial views of the internal and external structure of materials. However, due
to the low divergence of the x-ray beams produced by synchrotron radiation, x-ray
microtomography can achieve approximately one thousand times better spatial resolution
than that of conventional CT [16]. The in-plane pixel size in the present report was 13
µm and the slice thickness in the reconstructed 3-D images was 13 µm. In-situ x-ray
diffraction (XRD) measurements were performed simultaneously by aperturing and
localizing the x-ray beam onto the calcification in question. The approach of combining
high-resolution 3-D visualization and in-situ XRD represents a significant advance in
visualizing and identifying atherosclerotic calcifications.
Experimental Section
The monochromatic XMT measurements were conducted in vitro [17] on human
atherosclerotic arteries that were removed from three white males. Their ages were 51,
55, and 70, denoted sample A (SA), sample B (SB), and sample C (SC), respectively
[18]. From a series of radiograms taken at sample orientations in 0.25 degree increments,
a tomogram was reconstructed in the interactive data language (IDL) programming
environment (19) using a filtered back-projection algorithm [20]. The reconstructed
slices provide the x-ray mass density at each point in a sample. The reconstruction was
performed using a fast Fourier Transform algorithm following a re-gridding from a polar
to Cartesian coordinate system [20]. Typical reconstructed volumes involved 658 × 658
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× 517 arrays. Further 3-D visualization and image analyses were done using IDL. This
research emphasized the visualization and characterization of calcified plaque.
Results and Discussion
The coronary arteries used in these experiments were completely or partially
obstructed (Figures 4.1A and 4.1B). For the native arteries, only the lumen of the
sample SA was open throughout the 6.8 mm long segment. The diameter of the lumen
decreased monotonically from one end of the artery to the other by 57.5%. Although this
artery was not completely occluded like the others, it still had a large amount of
clustering on the arterial wall.

Recent studies have shown that during plaque

development, there is "remodeling" of the artery wall, which maintain the lumen size. As
atherosclerosis progresses, the "remodeling" is overcome by plaque development, and
stenosis occurs. [3, 13]. Therefore, visualization of arterial wall is more important than
that of lumen for the characterization of the atherosclerotic disease.
Three types of plaque compositions were distinguished based on the brightness of
the image. The low-density component was identified as lipid-rich deposits, while the
medium density was fibrous plaque. The high mass density component was identified as
calcified particles [10, 21]. These three phases were separately observed using the
absorption profile (Figure 4.1C). The absorption of the fibrous plaque at 12.5 KeV x-ray
energy was about 0.003 (twice as the fatty plaque). The calcium deposit had a higher
absorption, i.e. approximately 10 times higher than the fibrous plaque. The cross section
sequence images of the native arteries perpendicular to the z-, x-, and y-axis show the
morphologies and the distributions of the plaque components in atherosclerotic arteries in

82

three different directions. Some calcified plaques were separately distributed as small
clusters, while others were large continuous pieces along the longitudinal direction (zaxis). The calcification density was greater at the edge of the interior (Figure 4.1C).
The bypass arteries showed less calcification in amount and size. The volume ratios of
calcification to artery wall of the three natural samples were 3.7 ± 0.2%, 6.0 ± 1.3%, and
20 ± 3%, respectively. The ratios for the bypass specimens were only 0.025 ± 0.004%,
0.032 ± 0.007%, and 0.021 ± 0.002%, respectively [23]. These ratios were hundred times
lower than in the native deposits.
The high-density plaques were confirmed to be calcium deposits by in situ
powder x-ray diffraction. Figure 4.2 illustrates the x-ray diffraction patterns in the native
and the bypass coronary arteries, respectively. The calcifications in native arteries were
more crystalline than those in the bypass arteries. The equivalent 2θ scan diffraction
patterns were obtained when the Debye-Scherrer rings were integrated (Figure 4.2C).
(23). Each ring or peak was indexed by diffraction features of hydroxyapatite (HAP),
Ca10(PO4)6(OH)2, with a hexagonal configuration with lattice constants of a = 9.424 Å, c
= 6.879 Å. The fact that no single unknown peak was found indicates that the majority of
the crystalline component of a calcified plaque was composed of HAP. In addition, there
was an amorphous phase that contributed to the broadening of the peaks. Small HAP
crystal depsoits were observed on the arterial walls when scanning electron microscopy
(SEM) was used [25-28]. The crystals were reported to be 1-30 µm in diameter, and they
were heterogeneously distributed. The amorphous phase corresponds to the connective
tissue that has a long-range periodic structure.
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Figure 4.1 Cross sectional image sequences along the three different directions.
Sample A, B, and C were from the coronary arteries of a 51, 55 and 70
year old white male, respectively. The presence of calcium is indicated
by the color. Increasing concentration of calcium changes color from
orange to yellow.
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Figure 4.2. Powder x-ray diffraction patterns of calcium deposits. In situ XRD
patterns were acquired at the same beamline (17) by narrowing the
synchrotron radiation x-ray beam. The incident monochromatic x-ray
energy was 25 KeV, equivalent to 0.496 Å wavelength that is 3 times
shorter than that of the frequently used Cu Kα radiation. (A) DebyeScherrer pattern of one calcium deposit in the SC native artery and (B)
in the SB bypass artery.

In the translucent images of native and bypass arteries shown in Figures 4.3A and
B, the morphology, the size, and the distribution of the calcified tissues can be visualized
intuitively. A large amount of the calcifications in the native arteries are preferentially
deposited along the longitudinal axes of the arteries, and they have cylinder like shapes
(Figures 4.3C and D). Only a few small calcifications were found in the bypass arteries.
The data suggest that larger calcium accumulations occurred over a longer period of time.
It was also observed that not all large calcifications had closed cylinder-like shapes. On
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the contrary, the calcifications confined by the artery wall had a curve-like shape (Figure
4.3E).

Figure 4.3 (A-E). Visualization of calcification in coronary arteries.
The x-ray absorption features of the calcium deposits in the native arteries are
different from those in the bypass. The mass densities of the calcified plaques in native
arteries are much higher at the edge than in the interior (Figure 4.4A), whereas the
highest attenuations occur in the centers of calcium deposits in the bypass specimens
(Figure 4.4B). This difference shows that the HAP crystals nucleated in the tissue matrix
may develop or move towards the outer surface of the calcified tissue over time. This
results in a more dense distribution or larger crystalline grains near the edges. The
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attenuation coefficients, µ, of the fatty and fibrous plaques are very close to those of the
adipose and soft tissues (Table 4.1). Assuming the calcified plaque is only composed of
HAP crystals (neglecting the trace amount of metals Mg, Na and Fe [28] and connective
tissue, the attenuation contribution fraction, x, of HAP crystals in the edge or interior of
the calcifications was estimated by use of the equation
µmeasured = x ∗µHAP + (1-x) ∗ µtissue,
the results are listed in Table 4.2. The maximum attenuation coefficient is less than 1/3
of the value of pure HAP, and the resulting percentages of HAP range from ~ 4 to ~ 22%.

Figure 4.4 Experimentally measured linear attenuation coefficient of the calcified
plaques. (A) In each native artery. The monochromatic energies are 13.5,
12.5 and 11 keV for the SA, SB and SC arteries, respectively. (B) In each
bypass artery. The x-ray energies are 12.5, 12.5 and 15 KeV for the SA,
SB and SC, respectively. The calcified tissues in the native arteries were
selected from the planar cross-sections of 340, 460 and 320, respectively,
and 56, 62 and 480 slices from the bypass arteries (Fig. 4.1A).
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Table 4.1 Attenuation coefficients µ in cm-1 for each component at various x-ray
energies (29). The densities of HAP, soft tissue and adipose tissue are 3.14,
1.0 and 0.95 g/cm3, respectively [29]. The values were taken from the
website of National institute of standards and Technology.
E (KeV)

µHAP (cm-1)

µTissue (cm-1)

µAdipose-tissue (cm-1)

11

114.5

3.8

2.4

12.5

76.7

2.6

1.7

13.5

59.8

2.1

1.4

15

45.2

1.6

1.0

Table 4.2 Fitted contributions of HAP and soft tissue to the measured µ values in the
calcified plaque.
At the µaver in native artery

At the µmax in bypass artery

(%)

SA

SB

SC

SA

SB

SC

HAP

38

38

38

19

28

30

Tissue

62

62

62

81

72

70

Contribution fraction

Conclusion
SR-XMT is a very competitive technique for the high resolution and 3-D
visualization of atherosclerosis.. Complementary techniques, such as SEM and XRD,
provided a complete characterization of atherosclerotic plaques. Although SEM has
higher spatial resolution than SR-XMT, it has a small 2-D viewing field.
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Part II. Characterization of Calcium Deposits in Human Atherosclerotic Plaques
Using X-ray, X-ray Diffraction, Light Microscopy, and Staining Methods
Introduction
Atherosclerotic plaque can be calcified or amorphous, according to the high or
low calcium content, respectively. Although the terms calcified and atheroma plaques
are used in the literature, other researchers refer to these as a fatty streak plaque or a
plaque with lesion, respectively [30]. It should be noted that plaque deposits generally
start with fatty streak, and they progress to form lesions. The different morphologies of
the plaque motivated the use of several techniques for the study of plaque deposits.
Different spectroscopic and imaging techniques have been used in order to gain more
insight on the co-localization of fatty components and calcium in the plaque. Selective
methods, such as tomography, magnetic resonance imaging, and histological studies have
been performed to characterize calcification [31,32].

The use of high-resolution

tomography method allowed distinction and quantification of the presence of calcium in
clogged arteries [33]. Other methods include scanning electron and light microscopies,
which were used to assess the structural features of the atherosclerotic plaques [34].
Recently, Sarig et al. have successfully demonstrated the association of calcium
apatite and cholesterol in atherosclerotic plaques utilizing confocal microscopy [35]. In
this study, the determination of the cholesterol distribution within calcified media was
conducted using a fluorescence staining method. The fluorescence stain probe, filipin,
has a high affinity for cholesterol and was able to show the location of cholesterol within
hydroxyapatite. The study concluded that cholesterol was incorporated within the
calcium-phosphate-cholesterol agglomerates. It should be noted that these methods focus
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on the localization of the mineralized plaque. However, they cannot distinguish between
the different possible chemical forms of calcium [34].
In order to distinguish between homogeneous, heterogeneous, and ulcerated
carotid plaques, Fourier Transform Infrared, Fourier Transform-Raman, and Near
Infrared spectroscopic studies have been performed [36,37]. Although such vibrational
analyses can provide more information regarding structures and morphology of the
plaque deposits, the results are usually complex due to possible interferences from the
sample matrix. Another difficulty associated with these studies is the complexity and
multiple steps required in sample preparations. Therefore, alternative methods have to be
considered. Wang et al. developed a magic angle spinning nuclear magnetic resonance
method, with minimum interference to characterize the different phases of human
endarterectomy plaques [38].

Based on the NMR chemical shifts, the latter study

concluded that the spectral properties of the phosphate groups in carotid plaques were
similar to those of hydroxyapatite in bone. In earlier studies, chemical analysis prior to
sample extraction, performed by Murungi and Robinson, highlighted substantial
differences of calcium and phosphorus contents between “old” and “new” formed
plaques. The terms “old” and “new” were used to describe the plaque deposits in native
and bypass arteries, respectively [39].
The chemical form of the calcium during the progression of the plaque has not yet
been thoroughly studied. For example, it is not clear whether hydroxyapatite is formed
during the initial formation of the plaque or if it appears only in the progressive form. It
is also not obvious that there are no other intermediates in the process of calcification.

90

Recently, x-ray synchrotron radiation spectroscopy has been applied in the investigation
of the calcium forms in proteins [44]. Furthermore, studies on bone samples were
performed using synchrotron x-ray absorption, x-ray diffraction, and thermal analysis.
The results indicated that the sample’s mineral phase was mainly disordered calcium
apatite with no evidence of calcium phosphate phase [44-46]. In fact, the latter studies
cannot detect calcium phosphate, even if it were present in the sample.

However,

different bone samples showed different carbonate content. In addition, the size and the
morphology of the bone mineral particles were not found to correlate with the type of the
bone. In addition, X-ray absorption near- edge structure (XANES) was used to determine
the complexes of different metal ions [41,42].

In particular, XANES was used to

determine the configuration of Ca-binding sites in calmodulin (CaM) [46]. The XANES
results were shown to depend on the ketone and carboxylic functional groups in
Calmodulin.
In this study x-ray methods, such as XANES and x-ray diffraction were used to
study human coronary artery plaque. In particular, the possible calcium forms in the
plaque were examined. Different chemical forms of calcium may also exist in the native
and bypass plaque deposits. Such differences might be due to the long life chemistry of
the native coronary artery as compared to recent events in the bypass. Therefore, the
methods used in this study provide a powerful tool for examining the coronary plaques
from native and bypass coronary arteries.
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Experimental Section
Materials
Calcium oxide (CaO), calcium hydroxide (Ca(OH)2), and hydroxyapatite
(Ca10(PO4)6(OH)2) were purchased from Sigma Chemical Co. (St. Louis, MO). Stearic
acid and palmitic acid calcium salts were obtained from Fluka (Milwaukee, WI). The
coronary plaques were donated by the Department of Pathology, Louisiana State
University (LSU) Health Science Center, New Orleans, LA.
Sample Preparation
Segments (20 to 40 mm in length) from the right half of the thoracic to abdominal
aorta and the left circumflex of the coronary arteries were collected from cadavers, and
they were subjected to XANES analysis without further pretreatment. The acquisition of
the calcium XANES spectra was performed after exposing a segment of plaque wrapped
with polypropylene (PP) film to the x-ray beam.
For the x-ray diffraction experiments, the heart plaque samples were dried under a
stream of nitrogen gas for 24 hours. Then, the samples were ground into a fine powder
using a mortar and pestle.

The plaque samples that were removed from the left

circumflex arteries could not be transformed into fine powder due to their amorphous
nature. Thus, the x-ray diffraction analysis was limited to only crystalline samples.
Sample Processing for Light Microscopic Analysis
The coronary artery plaque deposit sections were processed differently depending
on the experiments (SEM or light microscopy). Due to the complexity of the tissues,
intensive sample preparation was required in order to obtain reliable results. Initially, the
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tissue components were preserved by fixation to avoid composition change. For the
purpose of electron microscopic techniques, the tissue was cut into thin slides. Utilizing
tissue samples cut with different thicknesses, the depth profiling, and the mapping of Ca
were performed using electron microscopy.
Cross section cuts of the coronary arteries were performed. The performance of
the shape of the slides was examined before and after their fixation. Hence the results
indicated that the slides were more regular and uniform when the samples were preserved
prior to the cut. After that the samples were embedded in a supportive media [48]. The
light microscopy process required 4% formaldehyde (formalin) and paraffin as an
embedding medium. For scanning electron microscopy, the fixation process required 2%
glutaraldehyde and epoxy as an embedding medium. After fixation, the microscope
slides were treated with silver nitrate.
XANES Spectroscopy
All experiments were performed at the Center for Advanced Microstructures and
Devices (CAMD) Synchrotron radiation source at LSU, Baton Rouge, LA. The XANES
experiments were conducted using a beamline of x-ray light source operating at 1.3 GeV.
X-ray beams are produced by the linear accelerator, and they travel through a slit before
hitting the monochromator. The XANES spectra were recorded in total electron yield
(TEY) mode at a double monochromator (DCM) beam line that was equipped with Si
(111) crystals.

The monochromatic crystal radiation in the region of interest was

provided under the Bragg angle conditions. The intensity of the incident radiation was
measured using ionization chambers, containing 100 mbar helium. Signals were detected
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using a Lytle detector. The beamline was calibrated by the K-edge absorption that
corresponds to the white line of CaO at 4043 eV.

XANES spectra of synthetic
o

compounds were recorded in transmission mode at room temperature (25 C). The
atherosclerotic plaques were recorded in fluorescence mode because of the limited
amount of plaque samples. Winxas software was used for data analysis [49].
The XANES spectra were obtained by exposing the samples to monochromatic xray beams ranging from 3993 eV to 4093 eV. The absorption spectrum was monitored
while scanning the monochromator. Initially, a smooth baseline was observed when the
x-ray energy was increasing. This trend is continuous until an electron of the K shell is
excited or ejected corresponding to an edge jump.

The edge jump described the

transition of an electron from the ground state to the target with a vacancy in the
absorbing atom.

The total absorption µ (k) above the absorption edge is given by [46]

µ (k ) = µ
where

µ

0

0

( k )(1 +

x( k )) ,

(k) is the smoothly changing fraction of

µ (k ) ,

which corresponds to the

absorption coefficient of the isolated atom. The fine structure is given by

x( k ) , which

are the effects of the interference between backscattered and outgoing photoelectron
signal in the photo-absorption matrix element.
X-ray Powder Diffraction
X-ray powder diffraction data was obtained using a Bruker Advance D8 powder
diffractometer equipped with a focusing Ge (111) primary monochromator (CuKα1
radiation). Finely ground samples were placed on a zero background quartz sample
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holder. Intensity data was collected at ambient temperature in the 2θ range, between 10°
and 80°, with a step width of 0.02°, and a 2 s count time.
Results and Discussion
The Ca K edge x-ray absorption of calcium model compounds (Ca10(PO4)6(OH)2,
fatty acid calcium salts, and calcium sulfide) was measured (Figure 4.5). The results
showed that the spectrum of hydroxyapatite was characterized by one K edge peak, and
several weaker broad peaks. Two points of inflection were present in the hydroxyapatite
spectrum. The features described the presence of structural disorder due to the lack of
crystalline form of the hydroxyapatite sample. The smooth edge of the spectra showed
no inflection for the plaque samples. A less intense white line with first and second order
inflections was observed in Ca K edge XANES spectrum of hydroxyapatite. Above the
threshold, we observed shape resonances that resulted from multiple scattering in the
calcium local environment. The energy difference between the lower points of the edge
to the maximum point of the shape resonance was calculated, in order to compare the
differences in the XANES spectra between the plaque samples and standard calcium salt.
Figure 4.6 illustrates the XANES spectra of the plaques and the model compounds.

Figure 4.5 Ca K edge XANES spectra of model compounds.
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The amplitude ratio of the shape resonance to the edge jump was determined.
There were no major differences of )E (keV) between the plaque samples and the
standard calcium salts, except for calcium sulfide, stearic acid, and levulinic acid calcium
salts.

Figure 4.6 Ca K-edge XANES spectra of plaques and model compounds.

Structural studies using x-ray absorption fine structures (EXAFS) showed a
difference between the plaque deposits and calcium salt model compounds.

The

amplitude of the magnitude of the Fourier transform determined the radial distribution
function of the neighboring atoms. In the hydroxyapatite spectrum the distance of Ca to
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oxygen was given by the location of the first shell.

A relative shift of the first

coordination shell of the deposits to hydroxyapatite was observed. The amplitude and the
frequency of the Fourier transform EXAFS oscillations depended on the neighboring
atom, and the distance between the core atom and the ligand. Differences were observed
in the higher coordination shell above 1Å in all the spectra. This phenomenon was an
indication of possible differences in sample crystallinity. More crystalline samples tend
to be more ordered (Figure 4.7).
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Figure 4.7 Ca K edge EXAFS of coronary plaque deposits and hydroxyapatite.

The combination of XANES and EXAFS allowed us to observe both short and
long-range order, i.e differences between amorphous and crystalline materials.
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Additional data using x-ray diffraction of the plaque deposit samples may give more
details about the crystallinity of the deposits.
X-ray microanalysis
Scanning electron microscopy on crystalline and atheroma (amorphous) deposits
from native and bypass coronary plaques revealed irregular, rough, and amorphous
surface features. Simultaneous characterization using electron probe x-ray microanalysis
provides elemental composition of highly calcified and amorphous deposits. Qualitative
differences were observed. Calcium and phosphorus have the most intense signal in both
plaque segments (Figure 4.8). However, strong background interferences due to gold
coating materials were observed.

Figure 4.8 X-ray microprobe analysis of cross section cut of crystalline and
atheroma deposits.
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X-ray Diffraction Results
X-ray powder diffraction analyses were performed on the crystalline samples
from native and bypass coronary plaque deposits. Figure 4.9A-B showed the diffraction
patterns of the crystalline plaques and hydroxyapatite. Ca hydroxyapatite was used to
assign the x-ray diffraction patterns of the plaque deposits. The peaks on the x-ray
diffraction of hydroxyapatite were accounted for the hexagonal space group P63/m, a =
9.426 Å, c = 6.865 Å (JCPDS # 861203).

Figure 4.9 A) X-ray diffraction of hydroxyapatite and plaque deposits from native
and bypass coronary arteries of a 55 year old male. B) X-ray
diffraction of hydroxyapatite and plaque deposits from native and
bypass coronary arteries of an 70 years old male.
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These results were in agreement with the published powder diffraction data [51].
However, the broader peaks found on the x-ray spectra of the plaques were an indication
of the amorphous form of the plaques. Therefore, x-ray diffraction method can be used to
differentiate crystalline plaques from amorphous plaques.
Histochemical and Histopathological Studies of Native and Bypass Coronary
Arteries
The silver staining method was performed on microscope slides with plaque
deposits and calcium salts (hydroxyapatite, calcium sulfide, and stearic acid calcium
salts), in order to study the distribution and the chemical forms of calcium on the arterial
walls. In this method the fixed slides were washed with silver nitrate reagent. Then, the
silver nitrate reacted with calcium deposits to yield a dark brown spot [48,52,53].
A metal substitution method, known as Von Kossa’s technique, was performed to
characterize the calcium deposits in the native and bypass coronary plaque deposits. In
this method, calcium was replaced by silver and a metallic salt was formed with the
anions of the calcium salt. The dark spots indicated the presence of the reduced silver.
This revealed the location of the sites where calcium previously resided. The following
reaction mechanism describes the Ca displacement by Ag. The effect of the Ca ligand in
the results of the staining is not clear. Therefore, different Ca salts were also treated with
the Von Kossa silver stain.
Ca 2+ CO3 2- + 2[Ag+ + NO3-]
2H + + Ag2 CO3

Ag2 CO3 + Ca 2+ 2NO3Reduction

by strong light
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2Ag

+ H2O + CO3

The Von Kossa technique was applied to the detection of calcium deposits, and
the determination of their forms in native and bypass plaque deposits (Figure 4.10). In
Figure 4.11, the model compounds of Ca with silver stain are shown. The data indicated
that the stained native coronary plaque deposits show dark spots that were larger than
those in the stained bypass coronary plaque.

Figure 4.10 Microscope slides of native and bypass coronary arteies with no silver
stains on the slides.

Figure 4. 11 Stained calcium salts with silver nitrate.
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Conclusion
The results indicated that the XANES Ca K edge spectra of plaque deposits
followed similar trends. A slight shift of the Ca K edge spectra of the deposits relative to
that of hydroxyapatite was observed. This shift might be due to a possible change in the
Ca coordination. The EXAFS results demonstrated differences between the native and
the bypass plaque deposits. In addition, the EXAFS Ca K edges exhibited differences in
the spectra of the plaque and hydroxyapatite. The differences were demonstrated by a
shift of the first coordination shell in both spectra, which might be due to a change in the
Ca environment.
X-ray diffraction analysis indicated that only mineralized plaque deposits were
able to provide diffraction patterns similar to hydroxyapatite.

However, this latest

method failed to provide any information from the soft plaque, in which the forms of
calcium could be mainly organic. Furthermore, staining studies using Von Kossa method
showed that the distribution of the calcium on the arterial walls was heterogeneous.
Moreover, the staining method illustrated the formation of the large calcium aggregates
in the crystalline deposits.
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CHAPTER 5
CHARACTERIZATION OF PLAQUE DEPOSITS USING CHROMATOGRAPHIC
METHODS
Part I. Capillary Electrochromatography of Cholesterol and Its Esters
Introduction
Cholesterol is one of the main components of cell membranes and has several
functions in the body, including the synthesis of certain hormones such as vitamin D and bile
acid. However, too much cholesterol may be dangerous since it is believed that accumulation
of cholesterol in the walls of arteries and veins accelerates the formation of atheroclerotic
plaque and consequently inhibits blood transportation. In the human body, this accumulation
and inhibition of blood flow can be fatal by causing strokes and heart attacks [1-3]. Thus,
accurate analytical tools for characterizing cholesterol are needed.
Over the years, gas chromatography (GC) has been used to characterize cholesterol
and its derivatives [4,5]. Usually, the GC analysis of a complex mixture of cholesterol
derivatives provides poor resolution due to the structural similarity of these compounds.
Therefore, capillary columns with high efficiency are necessary. Fused silica coated with
50% phenol and 50% dimethylsiloxane has been successfully tested to separate a mixture of
eighteen cholesterol oxidation products [4]. However, baseline separation of all cholesterol
derivatives were not obtained. In general, GC and GC/MS methods have serious limitations
including the need for thermally stable columns and cholesterol derivatization [6-8].
Reversed phase HPLC with evaporative light scattering (ELS), refractive index, and
electrochemical detection methods have also been reported for monitoring cholesterol
derivatives [9-13]. Duncan et al.[11] performed the quantification of free, total, and esterified
cholesterol extracted from human blood serum using HPLC. Suarna et al.[14] characterized

107

the oxidized lipid products extracted from human artherosclerotic plaques using reversedphase HPLC, and quantified the α-tocopherol and ascorbate present in the extracted materials.
These authors [15] also separated and characterized extracted cholesteryl, oxo- and hydroxylinoleate from human heart. The identification of extracted materials was achieved by
performing semi-preparative HPLC, and then individual fractions were collected and analyzed
by use of mass spectrometry with chemical ionization.

Murungi and Robinson [16]

characterized cholesterol, cholesteryl arachidonate, palmitate, and stearate extracts from
bypassed and non-bypassed heart plaque arteries using normal phase HPLC. In comparison
with the existing electrophoretic separation techniques such as capillary elecrophoresis (CE),
HPLC has low column efficiency due to the need for pressure driven flow. In addition, there
are limitations due to UV-cutoff of organic solvent, which is often close to the λmax of
cholesterol and its ester derivatives. Although ELS or mass spectrometry detection could be
employed to overcome this problem, the choice of mobile phase is limited and the solvent
residues can still affect the signal-to noise ratio.
To minimize solvent waste and improve the efficiency of the column, capillary
electroseparation methods have been performed to analyze neutral and charged species.
Micellar capillary electrophoresis (MCE) using sodium dodecyl sulfate (SDS) is a versatile
technique that separates both charged and neutral species. To separate very hydrophobic
neutral analytes, such as cholesterol esters, this technique does not appear to be a useful
complement to HPLC.

This is because such analytes often bind strongly to the most

commonly used micelles SDS and co-elute at the micelle migration time. To minimize the
strong interactions between SDS micelles and the cholesteryl esters, addition of organic
solvents to the MCE buffer is one option. However, the concentration of the organic modifier
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that can be used is limited by stability of the micelle. The addition of urea to the MCE buffer
may reduce the binding of hydrophobic molecules (e.g. corticosteroids) to SDS, although this
methodology may mask detection of cholesteryl esters at low wavelengths. Nishi et al., use
bile salts as another option for the separation of hydrophobic compounds [17]. However,
experience in our laboratory indicates that the use of this surfactant results in significantly
higher baseline noise at the low wavelengths which are required for detection of underivatized
cholesterol. Furthermore, recently microemulsion electrokinetic chromatography (MEEKC)
appears to be a promising technique for the separation of highly hydrophobic compounds [18].
However, selectivity of the technique appears to be limited due to band broadening. In
contrast, polymeric surfactants or micelle polymers, when used as a pseudo-stationary phase
show high tolerance to organic solvent with high separation efficiency [19-21].
Capillary electrochromatography (CEC) is a hybrid technique, which combines the high
efficiency of CE with the high selectivity of HPLC [22,23]. The separation mechanism in
CEC is guided by the electrophoretic mobility of the solutes and their partitioning between the
stationary phase and the mobile phase. As a consequence, selectivity in CEC and HPLC is
similar for neutral analytes. However, for charged species, it combines the attractive features
of electrophoretic and partitioning effects [24]. The technique continues to grow rapidly as
evident by more and more applications developed in the last few years [25-28]. Zare et al.
separated 15 of the 16 polycyclic aromatic hydrocarbons (PAHs) using CEC with an isocratic
mobile phase [25]. Recently, Yan et al.[26] separated all 16 PAHs using an ACN/H2O
gradient. Similarly, corticosteroids in biofluids have been analyzed in less than 14 minutes
using gradient elution [27]. In addition, triglycerides and free and derivatized fatty acids in
fish oil have been separated using CEC [28]. Therefore, CEC is well suited for the analyses of
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very hydrophobic compounds. This is because unlike MCE, high levels (40-80% (v/v)) of
organic solvents (acetonitrile, tetrahydrofuran and methanol) can be easily used in CEC to
adjust selectivity.
In this study, CEC is used to separate cholesterol and its ester derivatives. Several
chromatographic parameters such as buffer concentration, proportions of acetonitrile,
tetrahydrofuran and water, voltage, and temperature were evaluated to optimize the CEC
separation of a complex mixture of cholesterol derivatives with various chain lengths. The
possibility of combining CEC with EKC (using a polymeric surfactant) for improved
resolution of cholesterol esters is presented. To our knowledge, this is the first reported
application of CEC for the analysis of cholesterol and its ester derivatives.
Experimental Section
Reagents
Cholesterol (5-cholesten-3β-ol), cholesteryl acetate (5-cholesten-3β-ol 3-acetate),
cholesteryl n-butyrate (5-cholesten-3β-ol 3-butyrate), cholesteryl n-valerate (5-cholesten-3βol 3-pentanoate), cholesteryl n-hexanoate (5-cholesten-3β-ol 3-hexanoate), cholesteryl nheptanoate (5-cholesten-3β-ol 3-heptanoate), cholesteryl n-octanoate (5-cholesten-3β-ol 3octanoate), cholesteryl n-nonanoate (5-cholesten-3β-ol 3-nonanoate), cholesteryl n-decylate
(5-cholesten-3β-ol 3-decanoate), cholesteryl palmitate (5-cholesten-3β-ol 3-palmitate),
cholesteryl oleate (5-cholesten-3β-ol 3-oleate), cholesteryl linoleate (5-cholesten-3β-ol 3linoleate), cholesteryl laurate (5-cholesten-3β-ol 3-dodecanoate) and Tris[hydroxymethyl]amino-methane (Tris) were purchased from Sigma (St Louis, MO). Tetrahydrofuran (THF)
and acetonitrile (ACN) were obtained from Fisher (Springfield, NJ). Trifluoroacetic acid
(TFA) and hydrochloric acid (HCl) was purchased from Mallinckrodt (Paris, KY).
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Sample Preparation
Standards
Stock solutions of each analyte were prepared at concentrations of ~10 mg/mL in THF.
A 300 µL aliquot of each analyte was mixed and the solution was diluted with 1000 µL of a
mixture (50:50) of THF and ACN. The final concentration of each cholesteryl ester in a test
mixture was ca. 0.60 mg/mL.
Human Atherosclerostic Plaque
Plaque samples were obtained from the Pathology department of Louisiana State
University Medical School. The samples were collected from a 94-year old male cadaver.
Because atherosclerotic plaques are potentially biohazardous, all glassware and cutting tools
were carefully washed with a freshly prepared 10% Clorox solution. Lipid contents were
extracted from 1.20 g of wet specimen using a mixture of hexane/methanol/water (10:2:2
v/v/v). The hexane phase was separated and the solvent was evaporated under nitrogen. The
recovered dry lipid materials (Ca. 9.00 mg) were dissolved in 2 mL of mixture of THF and
ACN for CEC analysis.
Buffer Preparation
Buffers of 5, 10, 15, 20, and 25 mM of Tris were prepared and the pH was adjusted to
8.0 using 10 % TFA. THF and ACN were added to the buffer and the final solution filtered
using a polypropylene nylon filter with 0.45 µm pore size and sonicated for 10 min.
Instrumentation
Capillary electrochromatography (CEC) experiments were conducted using an HP 3DCE
system (Hewlett-Parkard, Wilmington, DE).

Data were collected using ChemStation

software. The CEC columns (100 µm i.d. x 357 µm o.d. x 30 cm total length, 20 cm to the
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detector) were packed with 3 µm Hypersil CEC C18 silica media according to the standard
procedure described by Boughtflower et al.[29]. The electrochromatograms shown in Figure
5.2 were obtained using a commercial C18 packed column (100 µm i.d. x 357 µm o.d. x 30
cm total length, 20 cm to the detector) purchased from Unimicro Technologies, Inc.
(Pleasanton, CA). The packed capillary column was preconditioned by applying the potential
in 5 kV increments for 10 minutes up to 25 kV. In between injections, the CEC columns were
conditioned for 5 min using 20 kV. All sample solutions were injected electrokinetically (10
kV, 3 sec.). All CEC separations were performed using 12-bar pressure applied to both ends
of the column to prevent bubble formation. Unless stated otherwise (e.g., Figure 5.6), the
capillary was kept at a constant temperature of 25 0C. The elution of the analytes was
recorded using a photodiode array detection system operated at three different wavelengths
(200, 214, and 220 nm) with % RSD of approximately 5.00 for the migration time of
cholesterol and its ester derivatives. Since the best signal-to-noise ratio was observed at 200
nm, this wavelength was used throughout the remainder of this study.
Results and Discussion
Cholesterol is a fat-soluble molecule. It belongs to a class of biological compounds
called sterols. Like all alcohols, it forms esters with fatty acids. Thus, the ester derivatives of
cholesterol are obtained by replacing the proton of the OH group by a fatty acid backbone
with a different chain length. Figure 5.1 shows the chemical structures of cholesterol and the
cholesteryl ester derivatives used in this study. The influence of operating parameters such as
type of acidic modifiers, organic solvent composition, buffer electrolyte concentration,
temperature, and applied voltage were studied to optimize the CEC separation of these
cholesterol esters.
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Figure 5.1 Chemical structures of cholesterol and twelve ester derivatives.
Effects of Organic Modifiers.
A stock solution of 25 mM Tris at pH 10 was prepared. To avoid the risk of mixed
retention and the dissolution of the silica bed, HCl and TFA were tested as acid modifiers to
adjust the pH of the running buffer to 8.0. Figure 5.2 compares the electropherograms for the
separation of cholesterol derivative mixture using isocratic CEC with HCl and TFA as acid

113

modifiers. Addition of HCl resulted in peak splitting and failed to prevent unwanted interaction
between the stationary phase and the analytes (Figure 5.2A).

Figure 5.2 Electropherograms of a mixture of cholesterol and twelve ester derivatives at pH
8.0. Using 25 % (v/v) THF/ 70 % (v/v) ACN /25 mM Tris. The pH of the
mobile phase was adjusted before the addition of the organic modifiers with (a)
HCl and (b) TFA. Conditions: 20 cm x 100 µm i.d. fused silica capillary
packed with 3 µm ODS particles; 200 nm UV detection; 25 kV voltage,
electrokinetic injection (10 kV for 3 sec). The peak identification is listed in
Figure 5.1.
In contrast, when the pH of the Tris was adjusted with TFA, better peak shapes (absence
of peak splitting) were observed (Figure 5.2B). The background current was 23 µA and 14 µA
using HCl and TFA, respectively. It is possible that the peak splitting observed with the use of
HCl may be due to joule heating cause by higher background current. To improve peak shape
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and resolution by suppressing interaction of the solutes with the silanol groups, all other CEC
separation were performed with Tris buffers adjusted to pH 8.0 with TFA.

Cholesterol

palmitate (11) and cholesterol oleate (12) did not elute even after 65 minutes.

Further

optimization was performed to reduce the analysis time.
Optimization of Mobile Phase Composition
The effects of mobile phase composition were also investigated. Solvent strength and
solvent UV wavelength cutoff were considered in the separation of cholesterol and its
cholesteryl esters. It is well known that THF has higher elutropic strength than most solvents.
It was found to be a good solvent candidate for fast, high efficiency separation of cholesterol
derivatives. In contrast, the UV cutoff for pure THF is around 214 nm. This would likely
increase the noise level and decrease the linear working range. However, the addition of H2O
and ACN decreases the relative background absorbance due to the dilution of pure THF. In
addition, the background effects of UV-absorbing solvents appear to be less critical in CE than
in HPLC, probably because of the use of the shorter pathlength in CE [30]. Consequently, a
series of experiments was conducted to optimize the CEC of 13 components of cholesterol
derivatives using various volume fractions of THF and ACN at a constant pH 8.0, and buffer
composition of 25 mM Tris. Figure 5.3 shows the separation profiles of cholesterol and its
ester derivatives using various percentages of THF and ACN. Although cholesterol (peak 1) is
less hydrophobic than the ester derivatives, it is more retained than the analytes 2, 3, 4, 5, and 6
(Figure 5.3). This suggests that cholesterol retention is likely governed by hydrogen binding
interactions between the hydroxyl groups and the free silanols on the wall of the column.
Therefore, cholesterol elutes as a result of polar and reversed-phase electrochromatographic
interaction. In contrast, the neutral ester derivatives of cholesterol elute from less to the more
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hydrophobic. Thus, the esters are separated based primarily on differential partitioning into the
alkyl-bonded phase. For example, cholesteryl oleate (12) and cholesteryl linoleate (13) each
have 18 carbons on the ester side chain.

However, cholesteryl linoleate (13) is more

hydrophilic (due to the presence of an extra double bond) and elutes before cholesteryl oleate
(12). As expected, migration time is reduced as a result of increasing THF concentration.
Overall, the elution order is not solvent dependent.

Figure 5.3 Effect of mobile phase composition on the CEC separation of cholesterol
derivatives. Conditions same as Figure 5.2 except TFA was used for pH
adjustment, and mobile phase (THF/ACN) composition was varied.
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When the volume ratio of THF was increased from 25% to 55% (v/v), the
electroosmotic flow increased by 10%. It is clear that an increase in the solvent strength (i.e.
increasing THF concentration) decreases the total separation time at the expense of lower
resolution and k’ values. At 25% (v/v) THF/70 % (v/v) ACN, the total separation is very long
and the last four cholesteryl derivatives (10, 11, 12, and 13) did not elute even after 80
minutes. Increasing the THF concentration to 35% (v/v) gives an elution window of about 70
minutes from the electrosmotic flow marker to the elution of cholesteryl laurate (peak 11).
All of the analytes elute in 20 minutes using 55% (v/v) THF. However, cholesterol and the
twelve-ester derivatives in the mixture are not well resolved. Taking into consideration the
resolution and speed of analysis, 35% (v/v) THF was used to further optimize separation
conditions for the mixture of cholesteryl esters.
Effect of Tris Concentration
The effect of Tris concentration on the CEC separation of cholesterol and its ester
derivatives was studied using 5 mM, 20, and 25 mM of Tris buffered at pH = 8.0. As shown
in Figure 5.4, both retention time and resolution of the analytes increase with increasing Tris
concentration from 5-25 mM. The increase in migration time is due to the interactions of Tris
with the silica surface, which can alter the zeta potential, and thus reduce the electrosmotic
mobility from 12.24 x 10-5 to 6.29 x 10-5 cm2 V-1 sec-1. In general, resolution for most analytes
increases with increasing Tris concentration due primarily to improved stacking during
electrokinetic injection. The use of even higher Tris concentration (>25 mM) was not feasible
due to longer retention times, which in turn leads to band broadening. Thus, a mobile phase
of 25 mM Tris was chosen in all subsequent experiments.
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Figure 5.4 Effect of Tris concentration on the CEC separation of a mixture of cholesterol
and twelve ester derivatives. Conditions same as Figure 5.2 except TFA was
used for pH adjustment, Tris buffer concentration was varied, with 35 % (v/v)
THF/ 60 % (v/v) ACN.
Effect of Applied Voltage
The influence of the applied voltage on the efficiency, resolution, and the analysis time
of the cholesterol esters were next evaluated using a mobile phase of 25 mM Tris in 35% (v/v)
THF/60% (v/v) ACN/ 5 % (v/v) H2O at 25 0C. As anticipated, a higher voltage reduced the
retention times due to an increase in the net velocity from 27.2 mm/s at 25 kV to 52.5 mm/s at
30 kV. At 30 kV, the short chain esters and cholesterol elute faster with poor resolution. In
contrast at 15 kV, separation of the mixture takes longer with less efficient peak separation.
Based on these results, the best resolution with higher efficiency was obtained using 25 kV
(see Figure 5.5).
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Figure 5.5 Effect of applied voltage on the CEC separation of a mixture of cholesterol and
twelve ester derivatives using 30, 25 and 15 kV. Conditions same as Figure 5.2
except applied voltage was varied from 15 kV to 30 kV. Mobile phase
composition was 25 mM Tris, 35 % (v/v) THF/60 % (v/v) ACN/ 5% (v/v) H2O,
(pH adjusted with TFA to 8.0).
Temperature Studies
An increase in temperature from of 20 to 60 0C was investigated in the CEC separation
of cholesterol derivatives. As shown in Figure 5.6, retention continues to decrease with an
increase in temperature, whereas resolution between adjacent peaks first improves than
deteriorates. An increase in temperature from 20 to 60 0C at 25 kV resulted in a 50%
reduction in analysis time due to an increase in electroosmotic velocity caused by lower
electrolyte viscosity. The peak resolutions significantly deteriorated at temperature > 40 0C.
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Based on these results, a temperature greater than 40 0C was chosen as optimum since it
produced baseline resolution of cholesterol and its ester derivatives in less than 40 minutes.

Figure 5.6 Effect of temperature on the separation of a mixture of cholesterol and twelve
ester derivatives. Conditions same as in Figure 5.6 except 30 kV was used and
the temperature was varied from 20 oC to 60 oC.
Effect of Pseudo-Stationary Phase: Polymeric Sodium N-Undecanoyl-Glycinate
It is now well documented that polymeric surfactants are stable even at high
concentrations of organic solvent, whereas normal (unpolymerized) surfactants are not [1719].

To investigate the effect of the polymeric surfactant, poly-sodium N-undecanoyl-L-

glycinate (poly SUG), separation voltage (30 kV) and temperature (25 0C) were chosen for
which the chromatographic resolution was relatively poor. Electrochromatograms using 25
mM Tris buffer with and without 5 mM of poly SUG at 30 kV are shown in Figure 5.7a and
5.7b, respectively. With no polymeric surfactant, the analytes are more retained because of
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the hydrophobic interaction between the analytes and the hydrophobic chain of the stationary
phase. The addition of (poly SUG) affects migration time and peak resolution. Shorter
migration time and improved resolution were observed due to interactions between the
polymer and the stationary phase, which in turn reduces the hydrophobic interactions of the
analytes with the stationary phase. In addition, critical peak pairs (peaks 3 and 4; peaks 1 and
7) were baseline resolved.

Therefore, due to improve efficiency upon the addition of

polymeric surfactant, the overall analysis time was reduced from 40 min to 35 min. Further
studies are underway to determine why only efficiency and not selectivity was influenced on
the addition of polymeric surfactant.

Figure 5.7 Effect of polymeric sodium N-undecanoyl-L-glycinate on the CEC separation of
a mixture of cholesterol and twelve ester derivatives. Conditions same as
Figure 5.6 except separation was performed at 30 kV and 25 oC. a) Tris buffer
(25 mM, pH 8) /THF/ ACN (5:35:60 v/v). b) Tris buffer (25 mM, pH 8) /THF/
ACN (5:35:60 v/v); with 5 mM polymeric sodium N-undecanoyl-L-glycinate.
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CEC Separation of Crude Extracts From Human Atherosclerotic Plaques
The samples involved in these CEC studies were mature plaques. The origin of such
plaques results from progressive alteration in the structures of the arterial walls [31]. Studies
have revealed that in later years, atherosclerotic plaques contain complex lipid deposits,
which are essentially large quantities of cholesterol and cholesterol esters. To identify the
lipid deposits, lipids extracted from plaque were removed from a segment of a human aorta
and injected into the CEC capillary. Figure 5.8 shows the presence of the cholesterol,
cholesterol linoleate, and cholesterol oleate contents in the plaque samples. As calculated
based on peak area, the lipid extracts from the plaque sample contains 55% of cholesterol
deposits with 20% cholesterol linoleate (13) and 24% cholesterol oleate (11).

Figure 5.8 CEC separation of crude extracts from atherosclerotic plaque of a human aorta.
Conditions are: Tris buffer (25 mM, pH 8) /THF/ ACN (5:35:60 v/v); with 5
mM polymeric sodium N-undecanoyl-L-glycinate using a 25 cm x 100 µm i.d.
fused silica capillary packed with 3 µm ODS particles; 200 nm UV detection; 30
kV voltage, electrokinetic injection (15 kV for 6 sec).
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Conclusion
This work has fully demonstrated that CEC could be used to characterize cholesterol
and cholesteryl esters extracted from atherosclerotic plaque deposits. In the CEC separation
the peak shapes of cholesterol derivatives were improved considerably when TFA was used as
an additive to adjust the pH of the running buffer to eight. Based on the poor solubility of the
cholesterol esters, a running buffer with a high concentration of organic solvent (THF and
ACN) was used as the mobile phase. The use of the polymeric surfactant, in the CEC buffer
decreased analysis time and improved resolution between two critical pairs of ester
derivatives (3/4 and 1/7).

Thus, baseline resolution of the 13-component mixture of

cholesterol was achieved with a separation time of less than 40 minutes with no need of prior
derivatization.

Alternatively, in the absence of the polymeric surfactant, an increase in

temperature to 40 0C provided baseline separation of the 13-component mixture on a similar
time scale. The optimized CEC method in the presence of the polymeric surfactant allows the
characterization of cholesterol, cholesterol linoleate, and cholesterol oleate present in human
aorta plaque.
Part II. Determination of Cholesterol and Its Esters in Plaque From Bypass and Native
Arteries From the Same Human Hearts Using Liquid Chromatography/ Atmospheric
Pressure Chemical Ionization Mass Spectrometry
Introduction
Many analytical methods have been used to study the composition of plaque deposits
including gas chromatography coupled with mass spectrometry (GC-MS), high performance
liquid chromatography (HPLC) to monitor the levels of cholesterol and related compounds in
plasma, tissues and food [32-35]. HPLC methods have often been utilized as an alternative
approach for the characterization of cholesterol and its ester derivatives [32-36].
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Detection

methods, such as light scattering, refractive index, or ultra visible light have also been applied
[37-40]. In each of these cases, the identification of the targeted analytes was determined using
migration time and spiking methods. In addition, mass spectrometry methods have been used to
identify the myriad of compounds involved [40-47].
Earlier studies in our laboratory showed that the calcium and phosphorus concentrations
in bypass deposits were significantly higher than in native artery deposits [16]. However, it
should be noted that these samples were obtained from bypass arteries that had become
completely occluded. In contrast, current samples were obtained from cadavers and were often
newly formed and different in texture.
The objective of this research is to examine the cholesterol components of deposits in
native and bypass deposits from the same heart and to note any differences. Such results can be
used to establish correlation between the cholesterol profile and the risk factors associated with
atherosclerosis. Therefore, quantitative determinations of cholesterol and cholesterol esters were
performed by use of chromatography and mass spectrometry.

Attempts to use liquid

chromatography coupled with electrospray mass spectrometry were unsuccessful because of the
complexity of the spectra. Atmospheric pressure chemical ionization mass spectrometry was
therefore used as the detection system since it avoids the necessity of derivatization. This
technique was successfully applied in this study. Large quantities of other compounds were
shown to be present. These have been qualitatively studied using 13C and 31P solid state NMR
[49].
Due to the complexity of the mixture of the crude extracts, UV and APCI detection
techniques were used to identify cholesterol and its esters in the plaque deposits. Successful use
of this method allowed a full characterization of cholesterol and its esters in the plaque deposits.
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Experimental Section
Reagents and Chemicals
The standards of cholesterol, cholesteryl linoleate, cholesteryl oleate, cholesteryl
palmitate, and stearate were purchased from Sigma (Milwaukee, WE) (Figure 5.9). Isopropanol,
acetonitrile, and formic acid were of HPLC grade and were obtained from Fisher Scientific
(Pittsburgh, PA). The human coronary plaque deposits were obtained through collaboration with
Dr. Richard E. Tracey from the department of Pathology of Louisiana State Health Centers in
New Orleans, LA.

Figure 5. 9. Structures of cholesterol and its esters.
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Sample Preparation
Standards
Standard solutions of cholesterol, cholesteryl arachidonate, cholesteryl linoleate,
cholesteryl oleate, and cholesteryl palmitate were prepared at concentrations of approximately
1.0 mg/mL in a 50:50 mixture of isopropanol and acetonitrile.
Atherosclerotic Plaque
The plaque samples from native and bypass coronary arteries were collected from
cadavers as listed in Table 5.1. The plaque deposits were obtained from the inner lining of an
artery. The sampling of the plaque was achieved by opening the arteries longitudinally and
peeling off the calcified and the fatty materials located in the interior of the tunica intima [31,50].
This study was to ascertain any differences in composition in bypass plaque (new) and native
plaque (old). Hence, the results may signify a change in body metabolism.
Plaque Extraction.
Approximately 0.1 – 0.2 g of samples were weighed. The cholesterol and its ester
derivatives were extracted with a mixture of chloroform/methanol/water (10:2:2 v/v/v) [51]. The
chloroform phase was separated, and the solvent evaporated under nitrogen. The recovered dry
lipid materials from the plaques (9.0 -5.0 mg) were dissolved in a 500 µL mixture (50:50) of
isopropanol/ acetonitrile for LC/ APCI MS analysis.
Instrumentation
HPLC APCI-MS System.
The cholesterol and cholesteryl esters in the crude extracts from the plaque deposits were
examined on a MarinerTM API-TOF Workstation from Applied Biosystems (Framingham, MA)
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coupled to an HP 1100 HPLC system with an autosampler and an UV-VIS detector (Paolo Alto,
CA). The separation was achieved using a Bischoff ProntoSil C18 column, 120 Å, 3 µm, 100 x
4.6 mm (Leonberg, Ger) with a solvent flow rate of 1 mL/min. A mixture of 30% isopropanaol,
70% acetonitrile, and 0.1% formic acid was used as the optimum eluent for separation of the
mixture of cholesterol and cholesteryl ester derivatives considering a 10 µL injection size.
Table 5.1. Source and description of the plaque deposits
Plaque deposit
Age

Gender

Description

Heart

Sample

Heart
1

1

70

Male

Native coronary artery

2

70

Male

Bypass coronary artery
tied to the left
circumflex

3

70

Male

Bypass coronary artery
tied to the right
coronary artery

4

70

Male

Bypass coronary artery

5

56

Male

Native anterior
descendant coronary
artery (highly calcified)

6

56

Male

Bypass coronary artery

7

56

Male

Bypass coronary artery

8

56

Male

Bypass coronary artery

9

56

Male

Native anterior
descendant

10

56

Male

Bypass coronary artery

11

56

Male

Bypass coronary artery

Heart
2

Heart
3
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The Ionization process was achieved with the Turbo Spray TM probe at a temperature of
400 °C at 4 kV. Acquisition of the mass spectra was performed within a scan range of 100 to
1000 Daltons with a scan rate of 1 spectrum per second. The ion count threshold was set at 1.0.
Results and Discussion
Separation of Cholesterol and Cholesteryl Esters Mixture
Optimum chromatographic resolution was obtained at room temperature using a mixture
of 70% acetonitrile, 30% isopropanol, and 0.1% formic acid as the mobile phase at a flow rate of
1.0 mL/min. After the successful optimized separation of HPLC analysis of cholesterol and
cholesteryl ester derivatives, calibration curves of cholesterol and cholesteryl ester were
performed. The data from standard mixtures are shown in Figure 5.10.

Figure 5.10. Standard chromatogram of cholesterol and its esters using ultraviolet
absorbance (λmax 200 nm). Mobile phase was a mixture of 30%/ 70%
isopropanol/ acetonitrile and Bischoff Prontosil C18 column, 120 Å, 3 µm, 100
x 4.6 mm at flow rate 1 mL/m.
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Calibration Standards
Figure 5.11 illustrates the calibration curve for cholesterol. A consistent linearity was
obtained from 0.2 mM to 1.5 mM for cholesterol and cholesteryl esters with linear regression (r2)
coefficient in the range of 0.99.
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Figure 5.11 (A-D) Calibration curves of A) cholesterol, B) cholesteryl linoleate, C)
cholesteryl oleate, D) cholesteryl palmitate. The conditions are
described in Figure 5.2.
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Characterization of the cholesterol and cholesteryl ester derivatives in plaque
deposits by the use of HPLC-APCI-MS
The APCI-MS results indicate that cholesterol and the cholesterol esters were present in
the plaque deposits in native and bypass coronary arteries. Figures 5.12 and 5.13 represent the
UV absorbance signals and the extracted ion chromatograms at m/z=369 of crude extracts from
the coronary plaque deposits from native and bypass arteries of the same heart, respectively. The
ion fragment at m/z=369 corresponds to loss of water or the fatty acid side chain for free
cholesterol or cholesteryl esters, respectively. Figures 5.14A and 5.14B illustrate the proposed
ionization mechanism of cholesterol and cholesteryl esters. The presence of cholesterol and its
esters in the crude extracts were confirmed using the retention times of the standard and the MS
fragmentation pattern.
The quantitation of cholesterol and its esters were obtained under identical conditions.
The peak areas of cholesterol and cholesteryl esters were integrated to calculate the
concentrations of cholesterol and its esters present in the crude extracts, and the results are
shown in Table 5.2. Cholesterol contributed as much as 34% and 32% in the native and bypass
deposits, respectively. In contrast, the total cholesteryl esters were detected as much as 23% in
the native coronary arteries and 16% in the bypass arteries.
The concentration of cholesterol was higher than the total concentrations of cholesteryl
esters. The total concentrations were higher in the native coronary plaque deposits than in the
bypass coronary plaque deposits. The clogged deposits in the bypass coronary arteries were
made of fibrous materials. Since the deposits in the native coronary artery occur over the life
span of the individual, it is likely that much more complex and crystalline materials are present.
These results were consistent with the values obtained for the analysis of the carotid plaques
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using previous techniques such as nuclear magnetic resonance (NMR) and Near Infrared (NIR)
spectroscopy [52, 53].

Figure 5. 12 A) UV trace of crude extracted from native coronary plaque. Mobile phase
was a mixture of 30%/ 70% isopropanol/ acetonitrile and Bischoff
Prontosil C18 column, 120 Å, 3 µm, 100 x 4.6 mm at flow rate 1 mL/min.
Numerous compounds beside cholesterol and cholesteryl esters were
detected. B) Chromatogram of crude extracted from native coronary
plaque deposits using m/z 369 as the detected fragment. Only cholesterol
and cholesteryl esters were detected using peak 369.
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Figure 5.13 A) UV trace of crude extracted bypass coronary plaque deposits. Mobile phase
was a mixture of 30%/ 70% isopropanol/ acetonitrile and Bischoff Prontosil
C18 column, 120 Å, 3 µm, 100 x 4.6 mm at flow rate 1 mL/min. Numerous
compounds beside cholesterol and cholesteryl esters were detected. B)
Chromatogram of crude extracted from bypass coronary plaque deposits
using m/z 369 as the detected fragment. Only cholesterol and cholesteryl
esters were detected using peak 369.
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Figure 5.14 Ionization mechanism of A) cholesterol and B) cholesteryl esters. The
ionization mechanism involved proton transfer.
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Table 5.2 Weight percent of cholesterol and cholesteryl esters from coronary plaque
deposits crude extracts
Plaque deposits

Cholesterol

Cholesteryl
linoleate

Cholesteryl
oleate

Cholesteryl
palmitate

Cholesteryl
stearate

Heart Sample
Weight %
Heart
1

Heart
2

1

11 ± 0.4

5.1 ± 0.2

0.5 ± 0.1

13.0 ± 0.2

5.0 ± 0.1

2

32 ± 1.0

1.4 ± 0.1

5.4 ± 0.4

*

*

3

6.0 ± 0.2

2.0 ± 0.1

2.0 ± 0.1

2.0 ± 0.1

0.8 ± 0.2

4

3.0 ± 0.1

0.02 ± 0.01

0.03 ± 0.01

2.0 ± 0.1

0.8 ± 0.2

5

18 ± 0.6

0.8 ± 0.1

1.0 ± 0.1

*

*

6

13 ± 0.5

0.01 ± 0.01

0.05 ± 0.01

2.0 ± 0.1

0.70 ± 0.2

12 ± 0.5

5.0 ± 0.2

7.0 ± 0.5

3.0 ± 0.1

1.2 ± 0.2

8

6.0 ± 0.2

2.0 ± 0.1

3.0 ± 0.2

*

*

9

34 ± 2.0

4.0 ± 0.1

1.0 ± 0.1

*

*

10

10.0 ± 0.4

0.8 ± 0.1

0.2 ± 0.1

6.0 ± 0.1

2.5 ± 0.2

11

30 ± 1.0

4.0 ± 0.1

0.7 ± 0.1

*

*

7

Heart
3

* Not detected.
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Conclusion
LC/APCI-MS analysis was successfully used to characterize native and bypass coronary
plaque deposits. Fragmentation patterns and migration times were used to determine cholesterol
and cholesteryl ester derivatives in the crude extracts from native and bypass coronary plaque
deposits. Overall, the concentrations of cholesterol were arguably higher in the native arteries
than in the bypass arteries. Surprisingly, the total concentration of cholesterol plus cholesteryl
ester derivatives was less than 40% of the total plaque in all the samples analyzed. Also
surprisingly, the cholesterol concentrations varied widely even within the same heart making
conclusions difficult to reach. Further, the concentration of the cholesterol was always higher
than the total concentration of all the esters. However, because of the small number of samples
analyzed, caution must be taken in interpreting these results, which suggest further work to
confirm the results here and a new study to identify the other 60% of the plaque.
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CHAPTER 6
CONCLUSIONS AND FUTURE STUDIES
Atherosclerosis is a disease caused by a blockage of the coronary arteries as a
result of an accumulation of cholesterol (and its esters), proteins, and inorganic materials
onto the arterial walls. Bypass surgery, which has been one of the most efficient methods
to cure the disease, remains very risky. Furthermore, the bypass veins that are used to
bypass the native artery generally fill with new deposits over few years. Therefore,
questions have been asked about the chemical differences between the two deposits, and
the chemical forms of calcium in these deposits.

To answer these questions, a

combination of analytical methods such as ICP-MS, solid state NMR, and
chromatography were used to characterize calcified and atheroma (amorphous) plaques
from native and bypass human coronary arteries from the same heart. In chapter 2 the
ICP-MS results indicated that the Ca/P ratio supported the view that the deposits existed
primarily as hydroxyapatite in the crystalline plaque.

However, the low total

concentrations indicated that the calcium deposits were not the major component of this
plaque, which appears to be organic in nature. The composition of the metal ions varied
widely in the same heart.

Na and Mg were higher in the soft plaque than in the

crystalline plaque, and Pb concentrations were higher in the crystalline deposits. Zinc,
Fe, Al, Si, Ba concentrations were very low. The concentrations of Ca and P were in mg
order of magnitude higher in the crystalline deposits than in the soft plaque.
In the atheroma plaque, some hydroxyapatite appears to be present, but much of
the phosphorus is organic in nature, possibly phospholipids or phosphoproteins. This
may be important since the soft tissue appears to be the early form of the plaque, which
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progresses to crystalline tissue over time. The organic phosphorus may be an important
component in the early formation of heart plaque. By the same token, the calcium may
play an equally important role at this and later stages. The low sulfur levels indicated that
homocysteine may play a role in plaque formation, but is not a major component.
In Chapter 3, Part I, cross polarization magic angle spinning NMR was applied
in the characterization of the plaques from native and bypass arteries. The solid state 13C
CP-MAS NMR indicated that the signal from the carboxylic group was mainly due to the
proteins and amino acid composition of the deposits. In addition, 31P NMR showed that
in the crystalline plaque only a single phosphorus resonance was observed which
overlapped with the chemical shift of the phosphorus in hydroxyapatite. Whereas, in the
amorphous plaque, two main resonance peaks were observed. One correlates with the
resonance chemical shift of phosphoorganic compounds and the other with
hydroxyapatite.
In Chapter 3, Part II, 13C CPMAS-NMR was also applied in the studies of the
interactions of Ca with homocysteine, cholesterol, and homocysteine-cholesterol. The
13

C NMR spectrum of homocysteine was compared to the

13

C NMR spectra of

cholesterol with and without Ca. The results showed that the addition of calcium with
cholesterol results in the resonance peaks of the alkene group being broader.
Furthermore, the NMR of the Ca-homocysteine precipitate showed a shift of the carbon
attached to the homocysteine sulfur group. Also a shift was observed at the carboxylic
group in comparison with free homocysteine.
In Chapter 4, Part I, in vivo x-ray microtomography and x-ray diffraction were
applied in the characterization of the crystalline and amorphous deposits from native and
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bypass coronary arteries from the same heart.

SR-XMT was shown to be a very

competitive technique in high resolution and 3D visualization of atherosclerosis in this
study. Complementary techniques such as SEM and XRD, can help to provide a complete
characterization of atherosclerotic plaques. In Chapter 4, Part II, additional studies
using x-ray absorption near edge structures indicated that the XANES spectra of deposits
and hydroxyapatite have similar trends. However, quick EXAFS analysis of the data
showed differences between the deposits and the hydroxyapatite. The results were able
to provide the Ca coordination and the distances of Ca to the O.
Solid-state studies using light microscopy in combination with silver staining
method on the slides were performed on the native and bypass coronary plaque deposits.
The results demonstrated that the color of the stains were comparable to the one obtained
with fatty acid calcium salts. In the bypass deposits Ca was evenly distributed, but in the
native deposits high concentrations of Ca were found at the interface and in the arterial
walls.
Finally the use of CEC and HPLC-APCI MS in Chapter 5 allowed us to
determine the concentrations of cholesterol and its esters present in the deposits. First,
the separation of a standard mixture of cholesterol and cholesteryl esters was optimized
using isocratic capillary electrochromatograpy (CEC) and reversed phase high
performance liquid chromatography (HPLC). Then, the same methods were applied to
measure the concentrations of cholesterol and its esters in the plaque. The concentrations
of cholesterol were higher in the native artery than in the bypass artery. The total
concentrations of cholesterol varied widely and were less than 40% in the plaque.
Furthermore cholesterol concentrations were higher than the total concentrations of
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cholesteryl esters in the deposits. The results showed that more materials (phospholipids,
proteins, and amino acids) were involved in the accumulation of the plaque.
Future Studies
Few studies have demonstrated that other chemicals in addition to cholesterol are
involved in the risks of coronary diseases [1,2]. One chemical that is associated with
atherosclerosis is homocysteine. It is thought that the complexation of homocysteine
with Ca is a contributing factor leading to the formation of plaque deposits [3]. The
results in Chapter 3, Part II, showed that Ca interacts with homocysteine and
cholesterol.

However, specific chemical composition was not characterized.

Thus,

further application using matrix assisted laser desorption mass spectrometry (MALDIMS) would determine the structure of the complexes [4].

Figure 6.1 Proposed studies of the effects of homocysteine and calcium in plaque
stability.
The study of the effects of homocysteine in the oxidation of cholesterol was also
proposed. Through these studies the effects of Ca on the activity of homocysteine would
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be determined. The reaction products would be monitored by mass spectrometry and
solid state NMR (Figure 6.1).
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